{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:24:17Z","timestamp":1791123857319,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":577,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000213.pub2","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T14:06:21Z","timestamp":1256133981000},"source":"Crossref","is-referenced-by-count":150,"title":["Thrombolysis for acute ischaemic stroke"],"prefix":"10.1002","author":[{"given":"Joanna M","family":"Wardlaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J","family":"del Zoppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"key":"10.1002\/14651858.CD000213.pub2-BIB3|cit1","first-page":"121","article-title":"Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis","volume":"113","author":"Abe","year":"1986","journal-title":"Folia Haematologica - Leipzig"},{"key":"10.1002\/14651858.CD000213.pub2-BIB4|cit2","first-page":"359","article-title":"Thrombolytic therapy for cerebral infarction","volume":"3","author":"Abe","year":"1984","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB1|cit3","first-page":"161","article-title":"Effect of oral urokinase and its clinical application","volume":"13","author":"Abe","year":"1982","journal-title":"The New Instanbul Contribution to Clinical Science"},{"key":"10.1002\/14651858.CD000213.pub2-BIB2|cit4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2491\/jjsth1970.12.321","article-title":"Clinical evaluation for efficacy of tissue cultured urokinase (TCUK) on cerebral thrombosis by means of multi-center double-blind study","volume":"12","author":"Abe","year":"1981","journal-title":"Blood & Vessel"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub2-BIB5|cit5","first-page":"1027","article-title":"Basic and clinical studies on oral urokinase and lysyl-plasminogen","volume":"25","author":"Naito","year":"1984","journal-title":"Rinsho Ketsueki"},{"key":"10.1002\/14651858.CD000213.pub2-BIB6|cit6","first-page":"128","article-title":"Australian streptokinase trial: clinical and CT outcome predictors","volume":"6 Suppl 2","author":"Davis","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB7|cit7","first-page":"183","article-title":"ASK trial: predictors of good outcome","volume":"6","author":"Donnan","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB8|cit8","first-page":"182","article-title":"ASK trial: risk factors for poor outcome","volume":"6","author":"Donnan","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"12","key":"10.1002\/14651858.CD000213.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","article-title":"Streptokinase for acute ischemic stroke with relationship to time of administration","volume":"276","author":"Donnan","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Donnan","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/978-3-642-78061-5_12","article-title":"Australian Streptokinase Trial (ASK)","volume-title":"Thrombolytic therapy in acute ischaemic stroke II","author":"Donnan","year":"1993"},{"key":"10.1002\/14651858.CD000213.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(95)92689-5","article-title":"Streptokinase in acute ischemic stroke","volume":"346","author":"Donnan","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB13|cit13","series-title":"Abstracts from the 6th International Symposium on Acute Stroke and Thrombolytic Therapy; 25-29 November 2000; Hamilton Island, Australia","article-title":"Early CT changes do not predict parenchymal haemorrhage following streptokinase therapy in acute stroke","author":"Gilligan","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/str.32.suppl_1.370-d","article-title":"Early CT changes do not predict parenchymal haemorrhage following streptokinase therapy in acute stroke","volume":"32","author":"Gilligan","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.50.3.626","article-title":"Streptokinase in acute stroke: effect on reperfusion and recanalisation","volume":"50","author":"Yasaka","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB16|cit16","first-page":"659","article-title":"Clinical utility of urokinase in the treatment of acute stage cerebral thrombosis: Multi-center double blind study in comparison with placebo","volume":"13","author":"Atarashi","year":"1985","journal-title":"Clinical Evaluation"},{"key":"10.1002\/14651858.CD000213.pub2-BIB17|cit17","first-page":"126","article-title":"The ATLANTIS rt-TP (alteplase) acute stroke trial: final results","volume":"9 Suppl 1","author":"Albers","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB19|cit18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.STR.31.4.811","article-title":"The rt-PA (alteplase) 0- to 6- hour acute stroke trial, part A (A027g). Results of a double-blind, placebo-controlled, multicentre study","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB18|cit19","first-page":"234","article-title":"The ATLANTIS rt-PA (alteplase) acute stroke trial - final results","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.STR.30.2.389","article-title":"Evaluation of early computed tomographic findings in acute ischaemic stroke","volume":"30","author":"Marks","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB22|cit21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/hs0202.102599","article-title":"The ATLANTIS trial: Results for patients treated within three hours of stroke onset","volume":"33","author":"Albers","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB21|cit22","first-page":"126","article-title":"The ATLANTIS rt-TP (alteplase) acute stroke trial: final results","volume":"9 Suppl 1","author":"Albers","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB23|cit23","first-page":"234","article-title":"The ATLANTIS rt-PA (alteplase) acute stroke trial - final results","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (alteplase) for ischaemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomised controlled trial","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB25|cit25","series-title":"Abstracts of the 7th International Symposium on Thrombolysis and Acute Ischaemic Stroke; 2002 May 27-28; Lyon","first-page":"79","article-title":"Do some patients benefit from rt-PA treatment for acute ischaemic stroke even when treated more than 3 hours after the onset of symptoms?","author":"Kent","year":"2002"},{"key":"10.1002\/14651858.CD000213.pub2-BIB26|cit26","first-page":"34","article-title":"Are asymptomatic intracranial hemorrhages really innocuous?","volume":"16 Suppl 4","author":"Kent","year":"2003","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.STR.0000051506.43212.8B","article-title":"Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?","volume":"34","author":"Kent","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB28|cit28","first-page":"188","article-title":"Australian Urokinase Stroke Trial","volume":"6","author":"Davis","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB29|cit29","unstructured":"Donnan G Australian urokinase stroke trial - AUST www.strokecenter.org\/trials\/list 2001"},{"key":"10.1002\/14651858.CD000213.pub2-BIB30|cit30","first-page":"25","article-title":"Australian urokinase stroke trial (AUST)","volume":"6 Suppl 2","author":"Donnan","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB31|cit31","series-title":"Programme and Abstract Book of the Stroke Society of Australasia; 1995 Annual Scientific Meeting; 1995 Oct 4-6; Melbourne","article-title":"Intra-arterial thrombolysis for basilar artery occlusion: Australian urokinase stroke study phase II results","author":"Gerraty","year":"1995"},{"issue":"1-2","key":"10.1002\/14651858.CD000213.pub2-BIB32|cit32","first-page":"A1","article-title":"Preliminary results of the AUST\/POST study","volume":"34","author":"Macleod","year":"2004","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000086121","article-title":"Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke","volume":"20","author":"Macleod","year":"2005","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000108174","article-title":"Thrombolysis in the vertebrobasilar circulation: the Australian urokinase stroke trial","volume":"7","author":"Mitchell","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB35|cit35","unstructured":"National Stroke Research Institute Preliminary results of the Australian urokinase stroke study\/posterior circulation thrombolysis study Powerpoint presentation"},{"key":"10.1002\/14651858.CD000213.pub2-BIB38|cit36","unstructured":"Intravenous thrombolysis with urokinase for acute cerebral infarctions. The study group of a 5 year National Project of the People's Republic of China, conducted by Qingtang Chen and Maolin He Chinese Journal of Neurology 2002"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB36|cit37","first-page":"7","article-title":"Intravenous thrombolysis with urokinase for acute cerebral infarctions","volume":"7","author":"Chen","year":"2001","journal-title":"Hong Kong Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB37|cit38","first-page":"210","article-title":"Intravenous thrombolysis with urokinase for acute cerebral infarctions","volume":"35","year":"2002","journal-title":"Chinese Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB39|cit39","first-page":"S7","article-title":"Intravenous thrombolysis with urokinase for acute cerebral infarctions","volume":"11 Suppl 1","author":"Wang","year":"2004","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000213.pub2-BIB40|cit40","unstructured":"Conroy MM Bat saliva drug may widen treatment window for stroke www.medscape.com"},{"key":"10.1002\/14651858.CD000213.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.STR.0000217403.66996.6d","article-title":"Dose Escalation of Desmoteplase for Acute Ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset","volume":"37","author":"Furlan","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB42|cit42","first-page":"36","article-title":"Desmoteplase in acute stroke - an integrated analysis of two phase II clinical trials","volume":"1 Suppl 1","author":"Hacke","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB43|cit43","unstructured":"PAION DEDAS www.paion.de\/"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB44|cit44","first-page":"656","article-title":"Recombinant desmodus salivary plasminogen activator (desmoteplase) in acute ischemic stroke","volume":"37","author":"Pugsley","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB55|cit45","unstructured":"No benefit of desmoteplase in acute ischemic stroke XVI European Stroke Conference"},{"key":"10.1002\/14651858.CD000213.pub2-BIB45|cit46","unstructured":"Eng P Spielhofen A DIAS-2. Desmoteplase in acute ischemic stroke-2 www.strokecenter.org\/trials\/TrialDetail.aspx?tid=515"},{"key":"10.1002\/14651858.CD000213.pub2-BIB50|cit47","unstructured":"Hacke W DIAS-2: No benefit of desmoteplase in acute ischemic stroke www.medscape.com\/viewarticles\/557663_print"},{"key":"10.1002\/14651858.CD000213.pub2-BIB47|cit48","first-page":"128","article-title":"The ongoing phase III study of desmoteplase in acute ischemic stroke","volume":"1 Suppl 1","author":"Hacke","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB48|cit49","first-page":"46","article-title":"The ongoing phase III study of desmoteplase in acute ischemic stroke","volume":"1 Suppl 2","author":"Hacke","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB46|cit50","first-page":"54","article-title":"Results from the phase III study of Desmoteplase in Acute Ischemic Stroke trial 2 (DIAS-2)","volume":"23 Suppl 2","author":"Hacke","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB49|cit51","doi-asserted-by":"crossref","unstructured":"Hacke W Furlan AJ Al-Rawi Y Davalos A Fiebach JB Gruber F Intravenous desmoteplase in patients with acute ischaemic stroke selected by MR perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study Lancet Neurology 2008","DOI":"10.1016\/S1474-4422(08)70267-9"},{"key":"10.1002\/14651858.CD000213.pub2-BIB53|cit52","unstructured":"Jeffrey S DIAS-2: No benefit of desmoteplase in acute ischemic stroke www.medscape.com\/viewarticle\/557663_print"},{"key":"10.1002\/14651858.CD000213.pub2-BIB54|cit53","unstructured":"Jeffrey S DIAS-2: patient enrolment resumes in trial of desmoteplase in stroke www.medscape.com\/viewarticle\/547120"},{"key":"10.1002\/14651858.CD000213.pub2-BIB51|cit54","unstructured":"Jeffrey S DIAS-2 revisited: development of desmoteplase for stroke to continue www.medscape.com\/viewarticle\/565145"},{"key":"10.1002\/14651858.CD000213.pub2-BIB52|cit55","unstructured":"Jeffrey S DIAS-2 revisited: development of desmoteplase for stroke to continue www.medscape.com\/viewarticle\/565145_print"},{"key":"10.1002\/14651858.CD000213.pub2-BIB57|cit56","unstructured":"PAION DIAS 2 www.paion.de\/"},{"key":"10.1002\/14651858.CD000213.pub2-BIB56|cit57","unstructured":"PAION AG Forest Laboratories Inc DIAS 2. Desmoteplase (INN) in acute ischemic stroke. Assessing treatment within 3-9 hours after onset of stroke symptoms paiondias.01kunden.net"},{"key":"10.1002\/14651858.CD000213.pub2-BIB58|cit58","series-title":"Proceedings of the International Stroke Conference; 2008 Feb 20-22; New Orleans","first-page":"LB P2","article-title":"Clinical benefit of desmoteplase treatment in patients with moderate to severe stroke: further results of the DIAS-2 trial","author":"Warach","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB59|cit59","first-page":"567","article-title":"Technology evaluation: desmoteplase, PAION\/Forest","volume":"6","author":"Debens","year":"2004","journal-title":"Current Opinion on Molecular Therapeutics"},{"key":"10.1002\/14651858.CD000213.pub2-BIB64|cit60","series-title":"The American Stroke Association 28th International Stroke Conference; 2003 Feb 13-15; Phoenix","first-page":"CTP14","article-title":"Desmoteplase in acute ischemic stroke (DIAS)","author":"Hacke","year":"2003"},{"key":"10.1002\/14651858.CD000213.pub2-BIB62|cit61","unstructured":"Hacke W Results of the phase II study DIAS Powerpoint presentation"},{"key":"10.1002\/14651858.CD000213.pub2-BIB63|cit62","series-title":"XVIIth International Congress on Fibrinolysis and Proteolysis; 2004 Mar 21-15; Melbourne","article-title":"The DIAS study: results of a phase II, MRI-based dose finding study of desmoteplase in acute stroke","author":"Hacke","year":"2004"},{"key":"10.1002\/14651858.CD000213.pub2-BIB61|cit63","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase In Acute ischemic Stroke trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB60|cit64","first-page":"69","article-title":"The results of the joint analysis of two phase II trials on desmoteplase in acute ischemic stroke with treatment 3 to 9 hours after stroke onset","volume":"19 Suppl 2","year":"2005","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB65|cit65","first-page":"S62","article-title":"Combined safety analysis of desmoteplase in acute ischemic stroke 3 to 9 hours after stroke symptom onset from two independent Phase II studies (DIAS and DEDAS)","volume":"238 Suppl 1","author":"Lees","year":"2005","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD000213.pub2-BIB66|cit66","unstructured":"PAION DIAS www.paion.de\/"},{"key":"10.1002\/14651858.CD000213.pub2-BIB67|cit67","unstructured":"Warach S for the DIAS Steering Committee Early reperfusion related to clinical response in DIAS: phase II, randomized, placebo-controlled dose finding trial of IV desmoteplase 3 - 9 hours from onset in patients with diffusion-perfusion mismatch www.abstractsonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&RecordID=11015"},{"key":"10.1002\/14651858.CD000213.pub2-BIB68|cit68","first-page":"409","article-title":"Randomized, placebo-controlled trial of IV desmoteplase 3 - 9 hours from stroke onset in patients with diffusion-perfusion mismatch: early reperfusion related to dose and therapeutic response","volume":"11","year":"2004","journal-title":"Proceedings of the International Society of Magnetic Resonance Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03530370021011","article-title":"Letter to the editor","volume":"275","author":"Ciccone","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1161\/01.STR.30.12.2631","article-title":"Neurological deterioration in acute ischaemic stroke. Potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I","volume":"30","author":"Davalos","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB71|cit71","first-page":"29","article-title":"Very early identification of lacunar infarcts in the ECASS Study","volume":"7 Suppl 4","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke","volume":"274","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB73|cit73","series-title":"The Challenge of Stroke. Lancet Conference; 1999 Oct 15-16; Montreal","first-page":"35","article-title":"Frequency and consequences of medical complications of ischaemic stroke","author":"Fieschi","year":"1999"},{"key":"10.1002\/14651858.CD000213.pub2-BIB74|cit74","first-page":"14","article-title":"Natural history of ischaemic stroke in ECASS 1 and ECASS II placebo cohorts","volume":"9 Suppl 1","author":"Fiorelli","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct. Relationships with early clinical deterioration and three month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB76|cit76","first-page":"19","article-title":"Cortical extension of the infarction at 24 hours in patients with isolated hypodensity of the lentiform nucleus on 1 - 6 hour CT: Incidence, predictors and outcome in the ECASS 1 cohort","volume":"8 Suppl 4","author":"Fiorelli","year":"1998","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jama.1995.03530130064029","article-title":"ECASS: Lessons for future thrombolytic stroke trials","volume":"274","author":"Fisher","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/01.STR.29.10.2073","article-title":"Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set. Post hoc analysis of ECASS 1","volume":"29","author":"Hacke","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB79|cit79","first-page":"984","article-title":"Reply to letter to the editor","volume":"275","author":"Hacke","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/01.STR.29.10.2073","article-title":"Dichotomised endpoints and combined global endpoint statistics applied to the ECASS intention-to-treat data set","volume":"29","author":"Hacke","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB81|cit81","first-page":"272","article-title":"rt-PA in acute ischaemic stroke - results from the ECASS three hour cohort","volume":"28","author":"Hacke","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB83|cit82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/978-3-642-78061-5_10","article-title":"The European Cooperative Acute Stroke Study (ECASS)","volume-title":"Thrombolytic therapy in acute ischaemic stroke","author":"Kaste","year":"1993"},{"key":"10.1002\/14651858.CD000213.pub2-BIB84|cit83","unstructured":"Kaste M Mau J Bluhmki E Del Zoppo GJ Orgogozo J-M Overgaard K A post-hoc risk\/benefit assessment for mortality and handicap in 615 ECASS patients randomised and treated Upsala Journal of Medical Sciences 1997"},{"key":"10.1002\/14651858.CD000213.pub2-BIB85|cit84","first-page":"S20","article-title":"Risk\/benefit assessment for mortality and handicap among 615 patients randomised and treated in ECASS","volume":"5 Suppl 1","author":"Kaste","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB86|cit85","first-page":"288","article-title":"Risk\/benefit assessment for mortality and handicap in ECASS randomised and treated patients: a post-hoc analysis","volume":"29","author":"Kaste","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB87|cit86","first-page":"129","article-title":"Potential contributors for good vs bad functional outcome or death in European Cooperative Acute Stroke Study (ECASS)","volume":"6 Suppl 2","author":"Kaste","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB82|cit87","first-page":"181","article-title":"Potential contributors to bad functional outcome or death in European Cooperative Acute Stroke Study (ECASS)","volume":"6","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB89|cit88","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.STR.28.5.957","article-title":"Hemorrhagic transformation in acute ischaemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study","volume":"28","author":"Larrue","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB88|cit89","first-page":"181","article-title":"Predictors of hemorrhagic transformation in the ECASS trial","volume":"6","author":"Larrue","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.STR.30.4.769","article-title":"Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator","volume":"30","author":"Manelfe","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB91|cit91","first-page":"55","article-title":"Would first-day body temperature dynamics contribute independently to long-term handicap after acute ischemic stroke?","volume":"21 Suppl 4","author":"Mau","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB93|cit92","first-page":"96","article-title":"First-day body temperature dynamics - a clinician's tool for monitoring penumbral tissue transformation and updating prognosis after ischemic stroke?","volume":"23 Suppl 2","author":"Mau","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB92|cit93","first-page":"30","article-title":"A robust prognostic advantage with \"late\" rising body temperature profiles in the ECASS-I data base","volume":"1 Suppl 2","author":"Mau","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB94|cit94","first-page":"1","article-title":"A risk\/benefit assessment of 1.1 mg\/kg iv rt-PA in 615 acute stroke patients of ECASS","volume":"7 Suppl 4","author":"Mau","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB95|cit95","first-page":"247","article-title":"Risk profile comparison in 615 patients randomised to either 1.1 mg\/kg intravenous rt-PA or placebo of ECASS 1","volume":"30","author":"Mau","year":"1999","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB96|cit96","first-page":"e189","article-title":"Beta-blockers with thrombolysis? Cautioning evidence from the ECASS-1 trial","volume":"35","author":"Mau","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/01.STR.30.3.502","article-title":"Delayed increase in infarct volume after cerebral ischaemia. Correlations with thrombolytic treatment and clinical outcome","volume":"30","author":"Pantano","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000015851","article-title":"The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification","volume":"8","author":"Steiner","year":"1998","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1468-1331.1995.tb00074.x","article-title":"European Cooperative Acute Stroke Study (ECASS): (rt-PA - thrombolysis in acute stroke) study design and progress report","volume":"1","year":"1995","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB100|cit100","first-page":"182","article-title":"Predictors of good outcome - ECASS trial","volume":"6","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiology.205.2.9356611","article-title":"Acute stroke - usefulness of early CT findings before thrombolytic therapy","volume":"205","author":"Kummer","year":"1997","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB108|cit102","first-page":"13","article-title":"Letter to the editor","volume":"275","author":"Kummer","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB102|cit103","first-page":"129","article-title":"Causes of death in ECASS","volume":"6 Suppl 2","author":"Willig","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB103|cit104","first-page":"272","article-title":"Heparin effects in the European Cooperative Acute Stroke Study","volume":"28","author":"Willig","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB104|cit105","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03530370021010","article-title":"Letter to the editor","volume":"275","author":"Wood","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB105|cit106","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.STR.0000189998.74892.24","article-title":"Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke","volume":"36","author":"Yong","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB106|cit107","first-page":"38","article-title":"Effect of thrombolysis on relationship between blood pressure and stroke outcome","volume":"21 Suppl 4","author":"Yong","year":"2006","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB107|cit108","first-page":"e218","article-title":"Comparison of blood pressure profiles between rt-PA and placebo in the ECASS-1 trial","volume":"35","author":"Yong","year":"2004","journal-title":"Stroke"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub2-BIB109|cit109","first-page":"2840","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (to the Editor)","volume":"359","author":"Fitzpatrick","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB110|cit110","first-page":"183","article-title":"European cooperative acute stroke study 3 (ECASS 3): study design and progress report","volume":"12 Suppl 2","author":"Hacke","year":"2005","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB112|cit112","unstructured":"Hacke W Kaste M Fieschi C Davalos A Larrue V Wahlgreen NG A placebo controlled trial of alteplase (rt-PA) in acute ischemic hemispheric stroke where thrombolysis is initiated between 3 and 4 hours after stroke onset. ECASS III www.strokeconference.org\/sc_includes\/pdfs\/CTP34.pdf"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub2-BIB113|cit113","first-page":"2841","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (the authors' reply)","volume":"359","author":"Hacke","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB114|cit114","unstructured":"Kaste M ECASS III The Third European Stroke Study www.stroke-forum.com\/news\/strokenews_benalmadena.pdf"},{"key":"10.1002\/14651858.CD000213.pub2-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMe0806335","article-title":"Thrombolytic therapy for acute stroke - not a moment to lose","volume":"359","author":"Lyden","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub2-BIB116|cit116","first-page":"2840","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (to the Editor)","volume":"359","author":"Morris","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub2-BIB117|cit117","first-page":"2840","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke (to the Editor)","volume":"359","author":"Schwamm","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD000213.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMc082179","article-title":"Thrombolysis 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Torbey","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB119|cit119","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/STROKEAHA.107.492330","article-title":"Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial","volume":"39","author":"Yong","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB120|cit120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(05)74844-3","article-title":"Letter to the editor","volume":"353","author":"Barer","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB121|cit121","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.STR.31.7.1545","article-title":"Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischaemic stroke and thrombolytic therapy","volume":"31","author":"Berrouschot","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB122|cit122","first-page":"95","article-title":"Reperfusion after focal cerebral ischaemia does not increase the rate and severity of secondary haemorrhage","volume":"9 Suppl 1","author":"Berrouschot","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB123|cit123","first-page":"267","article-title":"Thrombolysis with rt-PA: ASPECT study","volume":"30","author":"Berrouschot","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB125|cit124","first-page":"33","article-title":"Type of acute stroke care, stroke outcome and safety parameters in the ECASS II trial: the Spanish experience","volume":"9 Suppl 1","author":"Davalos","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB124|cit125","first-page":"9","article-title":"Fibrinolytic therapy for acute stroke: the Spanish experience","volume":"9 Suppl 3","year":"1999","journal-title":"Cerebrovascular Diseases"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD000213.pub2-BIB126|cit126","first-page":"5","article-title":"Assessment of ischemic damage on early CT with and without the use of a quantitative score","volume":"17","author":"Dzialowski","year":"2004","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB127|cit127","first-page":"636","article-title":"Extent of ischemic edema on CT before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II","volume":"37","author":"Dzialowski","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.STR.0000206215.62441.56","article-title":"Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II","volume":"37","author":"Dzialowski","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB129|cit129","first-page":"128","article-title":"Final results of the second European-Australasian Acute Stroke Study of intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"9 Suppl 1","author":"Fieschi","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB130|cit130","first-page":"14","article-title":"Natural history of ischaemic stroke in ECASS I and ECASS II placebo cohorts","volume":"9 Suppl 1","author":"Fiorelli","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB131|cit131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(98)00005-1","article-title":"ECASS II: Intravenous alteplase in acute ischaemic stroke","volume":"353","author":"Ford","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB135|cit132","first-page":"S9","article-title":"The results of the European Co-operative Stroke Study II (ECASS II), a placebo-controlled, randomized study of thrombolytic therapy","volume":"5 Suppl 3","author":"Hacke","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB133|cit133","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)74842-X","article-title":"Authors' reply","volume":"353","author":"Hacke","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB132|cit135","series-title":"The Challenge of Stroke, Lancet Conference; 1999 Oct 15-16; Montreal","article-title":"Thrombolysis in acute ischaemic stroke: ECASS II","year":"1999"},{"key":"10.1002\/14651858.CD000213.pub2-BIB136|cit136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)74843-1","article-title":"Letter to the editor","volume":"353","author":"Jenkinson","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB137|cit137","first-page":"278","article-title":"Risk factors for haemorrhagic transformation in ECASS II","volume":"31","author":"Larrue","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB138|cit138","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.STR.32.2.438","article-title":"Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator","volume":"32","author":"Larrue","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB139|cit139","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(05)74846-7","article-title":"Letter to the editor","volume":"353","author":"Lees","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB140|cit140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(05)74845-5","article-title":"Letter to the editor","volume":"353","author":"Raha","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB141|cit141","first-page":"576","article-title":"Rankin shift analysis of the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB142|cit142","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1161\/STROKEAHA.107.489351","article-title":"Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB143|cit143","first-page":"82","article-title":"European-Australian cooperative acute stroke study II (ECASS II) - interim demographics and baseline characteristics","volume":"8 Suppl 4","author":"Schaefer","year":"1998","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB144|cit144","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000047608","article-title":"Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial?","volume":"11","author":"Stingele","year":"2001","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB145|cit145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000068510","article-title":"Acute stroke trials: the problems of local investigators?","volume":"49","author":"Toni","year":"2003","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB146|cit146","first-page":"301","article-title":"Baseline CT findings and the response of thrombolytic treatment in acute ischemic stroke","volume":"221 Suppl","author":"Kummer","year":"2001","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB151|cit147","first-page":"275","article-title":"The effect of early and late brain tissue reperfusion on infarct volume","volume":"31","author":"Kummer","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB147|cit148","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/STROKEAHA.107.492330","article-title":"Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial","volume":"39","author":"Yong","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB148|cit149","first-page":"40","article-title":"Characteristics of blood pressure profiles and their prognostic value of stroke outcome","volume":"1 Suppl 1","author":"Yong","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB149|cit150","first-page":"34","article-title":"Review of characteristics of blood pressure profiles and long-term outcome in the ECASS-II database","volume":"1 Suppl 2","author":"Yong","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB150|cit151","first-page":"23","article-title":"Prognostic value of blood pressure profiles on cerebral hemorrhages in rt-PA treated patients","volume":"23 Suppl 2","author":"Young","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB152|cit152","unstructured":"Butcher K Davis S EPITHET protocol Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB153|cit153","unstructured":"Davis S Donnan G Echoplanar Imaging Thrombolysis Evaluation Trial http:\/\/www.strokecenter.org"},{"key":"10.1002\/14651858.CD000213.pub2-BIB155|cit154","unstructured":"Davis SM Donnan GA EchoPlanar Imaging Thrombolysis Evaluation Trial Powerpoint presentation"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB154|cit155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(08)70044-9","article-title":"Effects of alteplase beyond 3 hours after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial","volume":"7","author":"Davis","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB156|cit156","unstructured":"Di Silva D Data query for EPITHET Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB157|cit157","unstructured":"EPITHET Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET). Study protocol and prespecified statistical analysis plan http:\/\/www.astn.org.au\/epithet\/index.html"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB158|cit158","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1474-4422(08)70045-0","article-title":"EPITHET: failed chance or new hope?","volume":"7","author":"Schellinger","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB159|cit159","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.STR.24.7.1000","article-title":"Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke","volume":"24","author":"Haley","year":"1993","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB160|cit160","first-page":"203","article-title":"Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke","volume":"42 Suppl 3","author":"Haley","year":"1992","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB161|cit161","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-2007-1002675","article-title":"Clinical effects and basic studies of thrombolytic therapy on cerebral thrombosis","volume":"16","author":"Terashi","year":"1990","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD000213.pub2-BIB163|cit162","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/978-3-642-76439-4_20","article-title":"Thrombolytic therapy in embolic and thrombotic cerebral infarction: a cooperative study","volume-title":"Thrombolytic therapy in acute ischemic stroke","author":"Yamaguchi","year":"1991"},{"key":"10.1002\/14651858.CD000213.pub2-BIB162|cit163","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-78061-5_9","article-title":"Intravenous tissue plasminogen activator in acute thromboembolic stroke: A placebo-controlled, double-blind trial","volume-title":"Thrombolytic therapy in acute ischemic stroke II","author":"Yamaguchi","year":"1993"},{"key":"10.1002\/14651858.CD000213.pub2-BIB164|cit164","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000108714","article-title":"Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke","volume":"3","author":"Yamaguchi","year":"1993","journal-title":"Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub2-BIB165|cit165","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.STR.0000227191.01792.e3","article-title":"Alteplase at 0.6 mg\/kg for acute ischemic stroke within 3 hours of onset. Japan Alteplase Clinical Trial (J-ACT)","volume":"37","author":"Yamaguchi","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB166|cit166","first-page":"21","article-title":"Intra observer concordance of the neuroradiologic reviewing committee in CT scan reviewing in MAST-E","volume":"6 Suppl 2","author":"Besson","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB167|cit167","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Donnan","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB168|cit168","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/oxfordjournals.eurheartj.a015454","article-title":"TPA in acute stroke","volume":"18","author":"Hacke","year":"1997","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB169|cit169","first-page":"183","article-title":"Multicentre Acute Stroke Trial-Europe trial: predictors of good outcome","volume":"6","author":"Hommel","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB170|cit170","first-page":"182","article-title":"Multicentre Acute Stroke Trial-Europe trial: risk factors for the development of oedema, haemorrhage, bad neurological, bad functional outcome and death","volume":"6","author":"Hommel","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB172|cit171","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(95)91179-0","article-title":"Termination of trial of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Hommel","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB171|cit172","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)91179-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke (authors' reply)","volume":"345","author":"Hommel","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB173|cit173","first-page":"76","article-title":"Multicentre Acute Stroke Trial-Europe trial: predictors of good outcome","volume":"6 Suppl 2","author":"Hommel","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB174|cit174","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.STR.30.7.1326","article-title":"Haemorrhagic transformation in acute ischaemic stroke. The MAST-E Study","volume":"30","author":"Jaillard","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB176|cit175","first-page":"79","article-title":"Predictive factors related to outcome at one year after intravenous thrombolysis: the MAST-E study","volume":"10 Suppl 2","author":"Jaillard","year":"2000","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB175|cit176","series-title":"Abstracts from the 6th International Symposium on Acute Stroke and Thrombolytic Therapy; 2000 Nov 25-29; Hamilton Island (Australia)","article-title":"Predictive factors related to outcome at one year after IV thrombolysis\/the MAST-E study","author":"Jaillard","year":"2001"},{"key":"10.1002\/14651858.CD000213.pub2-BIB177|cit177","first-page":"189","article-title":"Predictive value of early CT signs in MCA occlusion","volume":"5","author":"Moulin","year":"1995","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB179|cit178","first-page":"182","article-title":"Haemorrhagic transformations in MAST-E trial: predictive factors","volume":"6","author":"Moulin","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB178|cit179","first-page":"128","article-title":"Predictive factors for hemorrhagic transformations in MAST-E","volume":"6 Suppl 2","author":"Moulin","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB180|cit180","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Shahar","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB181|cit181","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","article-title":"Thrombolytic therapy with streptokinase in acute ischaemic stroke","volume":"335","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB182|cit182","first-page":"129","article-title":"Long term effect of thrombolytic treatment in acute ischaemic stroke","volume":"6 Suppl 2","author":"Aritzu","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB183|cit183","first-page":"190","article-title":"Prognostic value of haemorrhagic transformations in acute ischaemic stroke","volume":"6","author":"Aritzu","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB184|cit184","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(96)90568-1","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Barer","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB189|cit185","series-title":"Book of Abstracts Proceedings of the 6th International Conference on Thrombolysis in Acute Ischaemic Stroke; 2000 Nov 25-29; Hamilton Island (Australia)","first-page":"3","article-title":"The long term effects of acute treatment with streptokinase and\/or aspirin","author":"Candelise","year":"2001"},{"key":"10.1002\/14651858.CD000213.pub2-BIB185|cit186","first-page":"393","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Candelise","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub2-BIB186|cit187","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/01.STR.31.7.1785","article-title":"Extraparenchymal bleeding predicts an unfavorable outcome in patients with hemorrhagic transformation","volume":"31","author":"Candelise","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB187|cit188","first-page":"23","article-title":"Aspirin given within 6 hours reduces long term case fatality but not stroke related disability","volume":"6 Suppl 2","author":"Candelise","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB188|cit189","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01995705","article-title":"Thrombolytic therapy. From myocardial to cerebral infarction","volume":"17","author":"Candelise","year":"1996","journal-title":"Italian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD000213.pub2-BIB190|cit190","first-page":"392","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Carolei","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB191|cit191","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000016026","article-title":"Negative interaction of aspirin and streptokinase in acute ischaemic stroke: further analysis of the Multicentre Acute Stroke Trial - Italy","volume":"10","author":"Ciccone","year":"2000","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB192|cit192","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(05)60007-4","article-title":"Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis","volume":"352","author":"Ciccone","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub2-BIB193|cit193","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/01.STR.31.7.1785","article-title":"Extraparenchymal bleeding predicts an unfavorable outcome in patients with hemorrhagic transformation","volume":"31","author":"Fiorelli","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB194|cit194","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(95)92043-9","article-title":"MAST-I: agreeing to disagree","volume":"346","author":"Horton","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB195|cit195","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/01.STR.28.2.302","article-title":"Reliability of hemorrhagic transformation diagnosis in acute ischemic stroke","volume":"28","author":"Motto","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB196|cit196","first-page":"129","article-title":"Aspirin in combination with thrombolysis increases the risk of early death but not of intracranial bleeding in patients with acute ischaemic stroke","volume":"6 Suppl 2","author":"Motto","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB197|cit197","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.STR.30.4.761","article-title":"Haemorrhage after an acute ischaemic stroke","volume":"30","author":"Motto","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB198|cit198","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(96)90568-1","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Muir","year":"1996","journal-title":"Lancet"},{"issue":"8989","key":"10.1002\/14651858.CD000213.pub2-BIB199|cit199","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB200|cit200","first-page":"392","article-title":"Multicentre Acute Stroke Trial - Italy","volume":"347","author":"Rothwell","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB201|cit201","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(95)92044-7","article-title":"Thrombolytic therapy for acute ischaemic stroke: promising, perilous or unproven?","volume":"346","author":"Sandercock","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB202|cit202","first-page":"198","article-title":"Is thrombolysis useful for acute stroke patients? The experience of the MAST-I study","volume-title":"Thrombolytic therapy in acute ischaemic stroke III","year":"1995"},{"key":"10.1002\/14651858.CD000213.pub2-BIB207|cit203","first-page":"181","article-title":"Risk factors in the MAST-Italy trial","volume":"6","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB203|cit204","first-page":"183","article-title":"Predictors of good outcome in the MAST Italy trial","volume":"6","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB204|cit205","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(95)92050-1","article-title":"Dissent: an alternative interpretation of MAST-I","volume":"346","author":"Tognoni","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB206|cit206","first-page":"2","article-title":"Thrombolysis in acute ischaemic stroke","volume":"1","author":"Wardlaw","year":"1996","journal-title":"Neurology Reviews International"},{"key":"10.1002\/14651858.CD000213.pub2-BIB205|cit207","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s004150050512","article-title":"The influence of baseline prognostic variables on outcome after thrombolysis","volume":"246","author":"Wardlaw","year":"1999","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB208|cit208","unstructured":"MELT MCA Embolism Local Fibrinolytic Intervention Trial http:\/\/melt.umin.ac.jp\/en\/"},{"key":"10.1002\/14651858.CD000213.pub2-BIB209|cit209","first-page":"16","article-title":"CT in acute stroke: learning from MELT-JAPAN","volume":"1 Suppl 2","author":"Mori","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB214|cit210","unstructured":"Ogawa MCA-Embolism Local fibrinolytic intervention Trial www.strokecenter.org\/trials\/TrialDetail.aspx?tid=589&printView=true"},{"key":"10.1002\/14651858.CD000213.pub2-BIB212|cit211","unstructured":"Ogawa A MCA-Embolism Local Fibrinolytic Intervention Trial http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=589"},{"key":"10.1002\/14651858.CD000213.pub2-BIB213|cit212","unstructured":"Ogawa A MCS embolism local fibrinolytic intervention trial http:\/\/center.umin.ac.jp"},{"key":"10.1002\/14651858.CD000213.pub2-BIB210|cit213","first-page":"519","article-title":"MELT Japan (MCA - Embolism Local Fibrinolytic Intervention Trial Japan)","volume":"64 Suppl 7","author":"Ogawa","year":"2006","journal-title":"Nippon Rinsho"},{"key":"10.1002\/14651858.CD000213.pub2-BIB211|cit214","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1161\/STROKEAHA.107.488551","article-title":"Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke. The Middle Cerebral Artery Embolism Local Fibrinolygic Intervention Trial (MELT) Japan","volume":"38","author":"Ogawa","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB215|cit215","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/STROKEAHA.107.490417","article-title":"Intra-arterial fibrinolysis for acute ischemic stroke. The message of MELT","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB216|cit216","first-page":"40","article-title":"Characteristics of blood pressure profiles and their prognostic value of stroke outcome","volume":"1 Suppl","author":"Yong","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB217|cit217","first-page":"I","article-title":"Intra-arterial urokinase infusion therapy in acute thromboembolic stroke","volume":"21 Suppl 1","author":"Mori","year":"1990","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB218|cit218","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.STR.19.7.802","article-title":"Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery","volume":"19","author":"Mori","year":"1988","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB219|cit219","first-page":"347","article-title":"Double-blind, placebo-controlled trial of recombinant tissue plasminogen activator (rt-PA) in acute carotid stroke","volume":"41 Suppl 1","author":"Mori","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB220|cit220","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.42.5.976","article-title":"Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke","volume":"42","author":"Mori","year":"1992","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB221|cit221","first-page":"727","article-title":"A pilot study of streptokinase for acute cerebral infarction","volume":"88","author":"Morris","year":"1995","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB222|cit222","doi-asserted-by":"crossref","first-page":"4p","DOI":"10.1042\/cs086004Pb","article-title":"Streptokinase for the treatment of acute cerebral infarction: a placebo controlled pilot study","volume":"86 Suppl 30","author":"Morris","year":"1994","journal-title":"Clinical Science"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB223|cit223","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/labmed\/27.5.296","article-title":"Heart treatment reduces damage from stroke","volume":"27","author":"Anonymous","year":"1996","journal-title":"Laboratory Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB224|cit224","unstructured":"Asplund K Goldfrank LR Ingall T Hertzberg V Louis T O'Fallan M Initial findings of the rt-PA acute ischemic stroke treatment review committee 2003"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB225|cit225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01376517-199712000-00006","article-title":"Nursing management of acute complications following rt-PA in acute ischemic stroke","volume":"29","author":"Barch","year":"1997","journal-title":"Journal of Neuroscience Nursing"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub2-BIB226|cit226","first-page":"2828","article-title":"Apo E phenotype and the efficacy of intravenous t-PA in acute ischemic stroke","volume":"31","author":"Broderick","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB227|cit227","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.STR.31.10.2335","article-title":"Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS t-PA Stroke Trial","volume":"31","author":"Broderick","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB229|cit228","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archneur.1996.00550120117025","article-title":"Thrombolysis for stroke","volume":"53","author":"Brott","year":"1996","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB228|cit229","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/01.STR.29.8.1504","article-title":"Hypertension and its treatment in the NINDS rt-PA stroke trial","volume":"29","author":"Brott","year":"1998","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB231|cit230","first-page":"320","article-title":"Predicting major neurological improvement with intravenous rt-PA treatment of stroke","volume":"34","author":"Brown","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB230|cit231","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.STR.0000105396.93273.72","article-title":"Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke","volume":"35","author":"Brown","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB232|cit232","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.59.5.669","article-title":"Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial","volume":"59","author":"Bruno","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB233|cit233","first-page":"693","article-title":"Percent change of neurological deficits in acute stroke: another useful outcome measure","volume":"39","author":"Bruno","year":"2008","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB234|cit234","first-page":"494","article-title":"The change in National Institute of Health Stroke Scale score over time in the NINDS rtPA stroke study","volume":"36","author":"Burger","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB323|cit235","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke (authors' reply)","volume":"334","author":"Zoppo","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB235|cit236","first-page":"448","article-title":"Importance of early ischemic CT changes using ASPECTS in NINDS rtPA stroke study","volume":"36","author":"Demchuk","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB236|cit237","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/01.STR.0000181116.15426.58","article-title":"Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA stroke study","volume":"36","author":"Demchuk","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB237|cit238","first-page":"521","article-title":"Predictors of slow recovery after acute ischemic stroke","volume":"38","author":"Elkins","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB239|cit239","first-page":"52","article-title":"Prompt tissue plasminogen activator therapy increased quality of life and reduced costs in acute ischemic stroke","volume":"September\/Octob","author":"Fagan","year":"1998","journal-title":"ACP Journal Club"},{"key":"10.1002\/14651858.CD000213.pub2-BIB238|cit240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.50.4.883","article-title":"Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke","volume":"50","author":"Fagan","year":"1998","journal-title":"Neurology"},{"issue":"18","key":"10.1002\/14651858.CD000213.pub2-BIB240|cit241","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/jama.287.18.2361","article-title":"Early ischemic changes on computed tomography in patients with acute stroke","volume":"287","author":"Fiorelli","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB241|cit242","first-page":"600","article-title":"How important is surrogate consent for stroke research?","volume":"39","author":"Flaherty","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB242|cit243","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199605233342114","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","author":"Freidman","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB243|cit244","unstructured":"Genetch Inc Activase for acute ischemic stroke. Clinical Review http:\/\/www.fda\/gov\/cber\/products\/altegen061896.htm"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB248|cit245","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/labmed\/27.5.296","article-title":"Heart treatment reduces damage from stroke","volume":"27","author":"Grotta","year":"1996","journal-title":"Laboratory Medicine"},{"issue":"3\/4","key":"10.1002\/14651858.CD000213.pub2-BIB249|cit246","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/jscd.2002.130044","article-title":"The NINDS Stroke Study group responses","volume":"11","author":"Grotta","year":"2002","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB245|cit247","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.STR.30.8.1528","article-title":"Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy","volume":"30","author":"Grotta","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB246|cit248","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/str.32.suppl_1.382","article-title":"Clinical deterioration following improvement in the NINDS rt-PA stroke trial","volume":"32","author":"Grotta","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB247|cit249","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.STR.32.3.661","article-title":"Clinical deterioration following improvement in the NINDS rt-PA stroke trial","volume":"32","author":"Grotta","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB244|cit250","unstructured":"Grotta J for the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group The NINDS Stroke Study Group Response http:\/\/www.bmj.com\/cgi\/eletters\/324\/7339\/723#23369"},{"key":"10.1002\/14651858.CD000213.pub2-BIB250|cit251","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0196-0644(97)99996-0","article-title":"Myths regarding the NINDS rt-PA stroke trial: setting the record straight","volume":"30","author":"Haley","year":"1997","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB251|cit252","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/01.STR.0000140891.70547.56","article-title":"Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial","volume":"35","author":"Ingall","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB252|cit253","first-page":"125","article-title":"Initial findings of the rt-PA acute stroke treatment review panel","volume":"16 Suppl 4","author":"Ingall","year":"2003","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB253|cit254","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/01.STR.0000242290.01174.9e","article-title":"Association of serial biomarkers with acute ischemic stroke: the National Institute of Neurological Disorders and stroke recombinant tissue plasminogen activator stroke study","volume":"37","author":"Jauch","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB254|cit255","first-page":"419","article-title":"Serial biochemical markers are associated with acute ischemic stroke in the NINDS rtPA stroke study","volume":"36","author":"Jauch","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB255|cit256","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.STR.0000047102.61863.E3","article-title":"Predicting outcome in ischemic stroke: external validation of predictive risk models","volume":"34","author":"Johnston","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB256|cit257","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1161\/01.STR.0000109768.98392.4D","article-title":"Risk adjustment effect on stroke clinical trials","volume":"35","author":"Johnston","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB257|cit258","first-page":"256","article-title":"Risk adjustment uncovers greater treatment effect in NINDS tPA trial","volume":"34","author":"Johnston","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB258|cit259","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.STR.0000090842.81076.68","article-title":"Are patients with acutely recovered cerebral ischemia more unstable?","volume":"34","author":"Johnston","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB259|cit260","first-page":"34","article-title":"Are asymptomatic intracranial hemorrhages really innocuous?","volume":"16 Suppl 4","author":"Kent","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB260|cit261","first-page":"576","article-title":"Modified Rankin score group distributions as a clinical trial end point: A NINDS tPA stroke study reanalysis","volume":"38","author":"Khatri","year":"2007","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub2-BIB261|cit262","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM199803123381112","article-title":"Should thrombolytic therapy be the first-line treatment for acute ischemic stroke?","volume":"338","author":"Kirshner","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB262|cit263","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jstrokecerebrovasdis.2003.09.001","article-title":"The effect of race and gender on patterns of rt-PA use within a population","volume":"12","author":"Kleindorfer","year":"2003","journal-title":"Journal of Stroke and Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB263|cit264","first-page":"1405","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","author":"Koroshetz","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB264|cit265","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.annemergmed.2004.06.021","article-title":"The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and stroke recombinant tissue plasminogen activator stroke study","volume":"45","author":"Kwiatkowski","year":"2005","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB265|cit266","first-page":"288","article-title":"The NINDS rt-PA stroke study: sustained benefit at one year","volume":"29","author":"Kwiatkowski","year":"1998","journal-title":"Stroke"},{"issue":"23","key":"10.1002\/14651858.CD000213.pub2-BIB266|cit267","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199906103402302","article-title":"Effects of tissue plasminogen activator for acute ischaemic stroke at one year","volume":"340","author":"Kwiatkowski","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB267|cit268","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.324.7339.723","article-title":"Alteplase for stroke: money and optimistic claims buttress the \"brain attack\" campaign","volume":"324","author":"Lenzer","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000213.pub2-BIB268|cit269","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bmj.325.7373.1131","article-title":"Controversial stroke trial is under review following BMJ report","volume":"325","author":"Lenzer","year":"2002","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB270|cit270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.11.002","article-title":"Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome","volume":"14","author":"Libman","year":"2005","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB269|cit271","first-page":"757","article-title":"Questioning thrombolytic use for cerebrovascular accidents","volume":"16","author":"Li","year":"1998","journal-title":"Journal of Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB271|cit272","first-page":"530","article-title":"Does stroke patient's weight influence the response to intravenous t-PA?","volume":"39","author":"Lou","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB272|cit273","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.STR.30.11.2347","article-title":"Underlying structure of the National Institutes of Health stroke scale. Results of a factor analysis","volume":"30","author":"Lyden","year":"1999","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB273|cit274","first-page":"56","article-title":"Underlying structure of the NIH stroke scale: results of a factor analysis","volume":"31","author":"Lyden","year":"2000","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB274|cit275","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.annemergmed.2005.01.030","article-title":"Stroking the data: re-analysis of the NINDS trial","volume":"45","author":"Magid","year":"2005","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB276|cit276","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/ewjm.176.3.192","article-title":"Truths about the NINDS study: setting the record straight","volume":"176","author":"Mann","year":"2002","journal-title":"Western Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB275|cit277","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.STR.0000152953.71415.01","article-title":"NINDS Reanalysis Committee's reanalysis of the NINDS trial (response)","volume":"36","author":"Mann","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB278|cit278","first-page":"244","article-title":"Earlier treatment associated with better outcome in the NINDS t-PA Stroke Study","volume":"30","author":"Marler","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB279|cit279","first-page":"244","article-title":"Earlier treatment associated with better outcome in the NINDS TPA Stroke Study","volume":"30","author":"Marler","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB280|cit280","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","article-title":"Early stroke treatment associated with better outcome. The NINDS rt-PA Stroke Study","volume":"55","author":"Marler","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB277|cit281","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB281|cit282","first-page":"524","article-title":"Congestive heart failure is associated with poor outcome at 6 months in patients with ischemic stroke","volume":"36","author":"Mohammad","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB282|cit283","first-page":"28","article-title":"Recent results from the NINDS-tPA trial","volume":"94 Suppl 167","author":"Morgenstern","year":"1996","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB283|cit284","first-page":"503","article-title":"IV rt-PA improves arterial recanalization rates and reduces infarct volumes in subjects with hyperdense artery sign on baseline CT","volume":"38","author":"Nichols","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB284|cit285","series-title":"Program and abstract book. 12th Nordic Meeting on Cerebrovascular Diseases; 2003 Sep 17-20; Oslo","first-page":"27","article-title":"The NINDS trial on t-PA in acute ischemic stroke revisited. Main results from an independent re-analysis of primary data","author":"O'Fallon","year":"2003"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB285|cit286","first-page":"496","article-title":"The smoking-thrombolysis paradox applies to stroke as well as MI: smoking has early beneficial effects following intravenous thrombolysis for acute ischemic stroke","volume":"36","author":"Ovbiagele","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB286|cit287","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1001\/jama.286.22.2830","article-title":"Lack of clinical significance of early ischaemic changes on computed tomography in acute stroke","volume":"286","author":"Patel","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB287|cit288","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(05)75572-0","article-title":"Early treatment of stroke with t-PA provides uncertain long-term benefits","volume":"353","author":"Pearson","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB288|cit289","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"334","author":"Quereshi","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB289|cit290","first-page":"658","article-title":"Is a maximum dose of 90 mg of recombinant tissue plasminogen activator in patients weighing greater than 90 kg justified?","volume":"37","author":"Qureshi","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB290|cit291","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1212\/01.wnl.0000208407.69544.5a","article-title":"Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?","volume":"66","author":"Qureshi","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB291|cit292","first-page":"493","article-title":"Analysis of patients with hyperdense artery sign in the National Institute of Neurological Diseases and stroke tissue plasminogen activator trial","volume":"36","author":"Qureshi","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB292|cit293","first-page":"532","article-title":"Aspirin failure does not increase the risk of recurrent stroke or death among patients with ischemic stroke","volume":"38","author":"Qureshi","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB295|cit294","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1161\/STROKEAHA.107.487009","article-title":"Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB296|cit295","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archneur.61.7.1066","article-title":"Number needed to treat estimates incorporating effects over the entire range of clinical outcomes. Novel derivation method and application to thrombolytic therapy for acute stroke","volume":"61","author":"Saver","year":"2004","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB293|cit296","first-page":"622","article-title":"Robust confirmation of treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB294|cit297","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.STR.0000254580.39297.3c","article-title":"Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB297|cit298","first-page":"576","article-title":"Rankin shift analysis of the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB298|cit299","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1161\/STROKEAHA.107.489351","article-title":"Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials","volume":"38","author":"Savitz","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB299|cit300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3949\/ccjm.63.2.77","article-title":"Therapy for acute ischemic stroke: the door opens. Interpreting the NINDS rt-PA stroke study","volume":"63","author":"Sila","year":"1996","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB300|cit301","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.STR.0000154861.96280.29","article-title":"NINDS stroke trial data reanalysis leaves issues unresolved (response)","volume":"36","author":"Smith","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB301|cit302","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5694\/j.1326-5377.2003.tb05603.x","article-title":"Thromobolysis for acute ischaemic stroke: revisiting the evidence","volume":"179","author":"Smith","year":"2003","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD000213.pub2-BIB302|cit303","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1212\/WNL.53.2.424","article-title":"Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey","volume":"53","author":"Tanne","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB304|cit304","first-page":"279","article-title":"Antiphospholipid antibodies and outcome of acute ischemic stroke in the NINDS rt-PA Stroke Trial","volume":"34","author":"Tanne","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB303|cit305","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/01.WNL.0000086809.46485.A1","article-title":"Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA stroke trial","volume":"61","author":"Tanne","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB305|cit306","first-page":"704","article-title":"Effect of elevated hemostatic markers on outcome after rt-PA therapy for acute ischemic stroke: results from the NINDS rt-PA stroke trial","volume":"37","author":"Tanne","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB306|cit307","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.STR.0000226897.43749.27","article-title":"Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke","volume":"37","author":"Tanne","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB315|cit308","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.STR.28.8.1530","article-title":"A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centres and implications for community practice and patient care","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB316|cit309","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1161\/01.STR.31.12.2912","article-title":"Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography","volume":"31","year":"2000","journal-title":"Stroke"},{"issue":"24","key":"10.1002\/14651858.CD000213.pub2-BIB317|cit310","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"333","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB314|cit311","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.annemergmed.2005.02.013","article-title":"Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA stroke study experience","volume":"46","year":"2005","journal-title":"Annals of Emergency Medicine"},{"issue":"11","key":"10.1002\/14651858.CD000213.pub2-BIB308|cit312","first-page":"2828","article-title":"Effect of rt-PA on CT lesion volume over time","volume":"31","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB309|cit313","series-title":"Proceedings of the 23rd International Joint Conference on Stroke and Cerebral Circulation; 1998 Feb 5-7; Orlando (FL)","first-page":"287","article-title":"Effect of rt-PA on ischaemic stroke lesion size by computed tomography: preliminary results from the NINDS rt-PA stroke trial","year":"1998"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB310|cit314","first-page":"241","article-title":"Tissue plasminogen activator for minor strokes: the NINDS rt-PA stroke study experience","volume":"35","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB311|cit315","first-page":"181","article-title":"Predictors of an unfavourable outcome","volume":"6","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB312|cit316","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/01.STR.28.11.2119","article-title":"Generalised efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA stroke trial","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB313|cit317","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral haemorrhage after intravenous t-PA therapy for ischaemic stroke","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB307|cit318","first-page":"182","article-title":"Predictors of favourable outcome","volume":"6","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB318|cit319","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/archneur.1997.00550240020008","article-title":"Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke","volume":"54","author":"Tilley","year":"1997","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB319|cit320","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ewjm.176.3.194","article-title":"Why were the benefits of tPA exaggerated?","volume":"176","author":"Trotter","year":"2002","journal-title":"Western Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB324|cit321","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.STR.31.1.231","article-title":"'Self-fulfilling prophecy' or recognition requires a concept of perception","volume":"31","author":"Kummer","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB320|cit322","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ewjm.176.3.198","article-title":"Thrombolysis for acute ischemic stroke: still a treatment for the few by the few","volume":"176","author":"Wardlaw","year":"2002","journal-title":"Western Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB321|cit323","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.annemergmed.2005.05.007","article-title":"Subgroups, reanalysis, and other dangerous things","volume":"46","author":"Wears","year":"2005","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB322|cit324","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/01.STR.0000030108.47462.4F","article-title":"Safety of tissue plasminogen activator for acute stroke in menstruating women","volume":"33","author":"Wein","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB325|cit325","first-page":"445","article-title":"Clinical efficacy of urokinase in patients with cerebral thrombosis: multicentre double blind study","volume":"19","author":"Ohtomo","year":"1985","journal-title":"Kiso-to-Rinshyo (Basic and Clinical)"},{"key":"10.1002\/14651858.CD000213.pub2-BIB326|cit326","first-page":"711","article-title":"Clinical efficacy of urokinase in the treatment of cerebral thrombosis. Multi-center double-blind study in comparison with placebo","volume":"13","author":"Ohtomo","year":"1985","journal-title":"Clinical Evaluation"},{"key":"10.1002\/14651858.CD000213.pub2-BIB330|cit327","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: A phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke","volume":"29","author":"Zoppo","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB331|cit328","first-page":"189","article-title":"Intra-arterial middle cerebral artery pro-urokinase acute stroke study","volume":"6","author":"Zoppo","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB327|cit329","doi-asserted-by":"crossref","first-page":"s44","DOI":"10.1185\/030079902125000723","article-title":"The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials","volume":"18 Suppl 2","author":"Furlan","year":"2002","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB328|cit330","first-page":"171","article-title":"The clinical trials acceleration program: experience from the Prolyse in Acute Cerebral Thromboembolism Trial (PROACT)","volume":"27","author":"Furlan","year":"1996","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB329|cit331","first-page":"CT 3","article-title":"Education, facilitation and motivation at clinical sites in an effort to increase patient enrolment in the PROACT Stroke Study","volume":"29","author":"Gutterman","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB332|cit332","series-title":"Proceedings of the 23rd Joint International Conference on Stroke and Cerebral Circulation; 1998 Feb 5-7; Orlando (FL)","article-title":"PROACT II: recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism","author":"Furlan","year":"1998"},{"key":"10.1002\/14651858.CD000213.pub2-BIB333|cit333","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intraarterial pro-urokinase for acute ischaemic stroke. The PROACT II Study: a randomised controlled trial","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB334|cit334","doi-asserted-by":"crossref","first-page":"s44","DOI":"10.1185\/030079902125000723","article-title":"The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials","volume":"18 Suppl 2","author":"Furlan","year":"2002","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD000213.pub2-BIB335|cit335","first-page":"234","article-title":"Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism: initial trial results. The PROACT investigators","volume":"30","author":"Furlan","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB336|cit336","first-page":"e3","article-title":"Early ischemic signs should not be used as exclusion criteria in thrombolysis trials","volume":"35","author":"Furlan","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB337|cit337","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.STR.0000107774.74679.16","article-title":"Early ischemic signs should not be used as exclusion criteria in thrombolysis trials","volume":"35","author":"Hamann","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB338|cit338","first-page":"e7","article-title":"Predicting functional outcome after intra-arterial thrombolysis: aspects of ASPECTS","volume":"35","author":"Hill","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB339|cit339","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.STR.0000237060.21472.47","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke. Analysis of the PROACT-2 Study","volume":"37","author":"Hill","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB340|cit340","first-page":"706","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study","volume":"37","author":"Hill","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB341|cit341","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.STR.0000082483.37127.D0","article-title":"Selection of acute ischaemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS","volume":"34","author":"Hill","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB342|cit342","first-page":"A260","article-title":"Symptomatic intracranial hemorrhage after intraarterial thrombolysis with recombinant prourokinase in acute ischaemic stroke: The PROACT II Study","volume":"54 Suppl 3","author":"Kase","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB343|cit343","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.STR.0000126043.83777.3a","article-title":"Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion","volume":"35","author":"Kim","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB344|cit344","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/str.32.suppl_1.336-b","article-title":"Angiographic collaterals in acute stroke - relationship to clinical presentation and outcome: The PROACT II Trial","volume":"32","author":"Roberts","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB345|cit345","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.STR.0000018011.66817.41","article-title":"Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischaemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial","volume":"33","author":"Roberts","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB346|cit346","first-page":"278","article-title":"Effect of intraarterial prourokinase on CT infarct volume: results of PROACT II","volume":"31","author":"Roberts","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB347|cit347","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.STR.0000237086.85164.92","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke: a plea to stop torturing the old data and do large trials!","volume":"37","author":"Sandercock","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB348|cit348","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/01.STR.0000107771.06671.7E","article-title":"Predicting functional outcome after intra-arterial thrombolysis: aspects of ASPECTS","volume":"35","author":"Saposnik","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB349|cit349","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/STROKEAHA.107.490417","article-title":"Intra-arterial fibrinolysis for acute ischemic stroke. The message of MELT","volume":"38","author":"Saver","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB350|cit350","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/str.32.suppl_1.319","article-title":"Factors influencing outcome and treatment effect in PROACT II","volume":"32","author":"Wechsler","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB351|cit351","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.STR.0000068782.15297.28","article-title":"Factors influencing outcome and treatment effects in PROACT II","volume":"34","author":"Wechsler","year":"2003","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub2-BIB352|cit352","first-page":"542","article-title":"Early intravenous thrombolysis with recombinant tissue plasmogen activator for acute cerebral infarction","volume":"15","author":"Wang","year":"2003","journal-title":"Chinese Critical Care Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB353|cit353","series-title":"Proceedings of the 4th International Conference on Research Advances in Cerebrovascular Disease; 2003 Oct 13-15; China","first-page":"201","article-title":"Clinical revaluation of intravenous thrombolysis with urokinase in treatment of acute cerebral infarction","author":"Bao","year":"2003"},{"key":"10.1002\/14651858.CD000213.pub2-BIB354|cit354","unstructured":"Boehringer Mannheim Double-blind, placebo-controlled, randomized multicenter study to evaluate the efficacy and safety of two doses of reteplase (r-PA_) (10 MU; 10 MU + 10 MU) in acute cerebral ischemia (MF 4398) Protocol 1994"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB355|cit355","first-page":"531","article-title":"The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke (the CLEAR stroke trial): final results from Tier I and II","volume":"39","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB356|cit356","first-page":"Abst 0270","article-title":"The usefulness of clinical-DWI mismatch in the treatment of acute ischemic stroke with reperfusion therapies","volume":"16 Suppl 4","author":"Davalos","year":"2003","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB357|cit357","unstructured":"Boehringer Ingelheim Defuse Powerpoint presentation"},{"key":"10.1002\/14651858.CD000213.pub2-BIB358|cit358","first-page":"46","article-title":"Hemodynamic stability during remifentanil or sufentanil anaesthesia in patients undergoing carotid endarterectomy (CE)","volume":"82 Suppl 1","author":"DeWinter","year":"1999","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD000213.pub2-BIB359|cit359","first-page":"76","article-title":"Intravenous versus intra-arterial urokinase thrombolysis in acute ischemic stroke. Randomised study of 27 patients","volume":"10 Suppl 2","author":"Ducrocq","year":"2000","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB360|cit360","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0150-9861(05)83018-4","article-title":"Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke","volume":"32","author":"Ducrocq","year":"2005","journal-title":"Journal of Neuroradiology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB361|cit361","unstructured":"Mori E Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB362|cit362","first-page":"251","article-title":"Edinburgh Stroke Trial. A pilot study of intra-arterial thrombolysis for acute ischaemic stroke","volume":"57","author":"Wardlaw","year":"1994","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub2-BIB365|cit363","first-page":"106","article-title":"The European multicentre four-arm trial in acute stroke project (EMFATAS): A European Union work - program on health research","volume":"9 Suppl 1","author":"Fieschi","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB363|cit364","series-title":"The Challenge of Stroke. The Lancet Confererence; 1998 Oct 15-16; Montreal","first-page":"36","article-title":"Early protocol of the European Multicentre Four-arm Trial in Acute Stroke (EMFATAS) of combination therapy in acute ischaemic stroke","author":"Fieschi","year":"1998"},{"key":"10.1002\/14651858.CD000213.pub2-BIB364|cit365","first-page":"192","article-title":"The EMPHATAS project: a four-arm safety and efficacy European trial","volume":"6","author":"Fieschi","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB366|cit366","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000068510","article-title":"Acute stroke trials: the problems of local investigators?","volume":"49","author":"Toni","year":"2003","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB367|cit367","series-title":"5th Thrombolysis in Acute Stroke Symposium, 1998 May 1-2; Bethesda","article-title":"Outcome of the EMS Trial patients without angiographically demonstrated arterial occlusion","author":"Derex","year":"1998"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB368|cit368","first-page":"273","article-title":"Combined intra-arterial and intravenous tPA for stroke","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB369|cit369","unstructured":"Sandercock P Interim results of EMS trial in acute ischaemic stroke Personal communication 1997"},{"key":"10.1002\/14651858.CD000213.pub2-BIB370|cit370","first-page":"184","article-title":"Combined intravenous and intra-arterial thrombolysis versus intra-arterial thrombolysis alone: preliminary safety and clot lysis","volume":"6","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB371|cit371","first-page":"9","article-title":"Antithrombosis enzyme vs dextran - 40 in treatment of acute cerebral infarction","volume":"4","author":"Fan","year":"2001","journal-title":"Henan Journal of Practical Nervous Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB372|cit372","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/01.STR.0000054627.69159.C2","article-title":"Emerging therapies for acute ischemic stroke: new therapies on trial","volume":"34","author":"Fisher","year":"2003","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub2-BIB373|cit373","first-page":"948","article-title":"Clinical observation of treatment through intravenous thrombolysis with low dose urokinase in 36 patients with advanced cerebral infarction","volume":"11","author":"Fu","year":"2004","journal-title":"Chinese Journal of Primary Medicine and Pharmacy"},{"key":"10.1002\/14651858.CD000213.pub2-BIB374|cit374","first-page":"108","article-title":"Is intravenous t-PA treatment beneficial in acute ischemic stroke related to internal carotid dissection?","volume":"23 Suppl 2","author":"Fuentes","year":"2007","journal-title":"Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub2-BIB375|cit375","first-page":"604","article-title":"Intravenous drip of urokinase combined with low molecular weight heparin in the treatment of acute cerebral infarction","volume":"21","author":"Geng","year":"2004","journal-title":"Practical Journal of Medicine and Pharmacy"},{"key":"10.1002\/14651858.CD000213.pub2-BIB376|cit376","first-page":"80","article-title":"Intravenous thrombolysis has a beneficial effect on clinical course but not infarct size in patients with supratentorial brain infarct","volume":"19 Suppl 2","author":"Hartmann","year":"2005","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB377|cit377","unstructured":"Kumana C Trial of intravenous streptokinase in Chinese patients with acute ischaemic stroke Unpublished"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB378|cit378","first-page":"378","article-title":"31 cases clinical report of snake venom IV on acute cerebral infarction","volume":"22","author":"Huang","year":"1996","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB379|cit379","first-page":"453","article-title":"Lumbrokinase in treating cerebral infarction","volume":"19","author":"Huang","year":"2000","journal-title":"Chinese Journal of New Drugs and Clinical Remedy"},{"key":"10.1002\/14651858.CD000213.pub2-BIB380|cit380","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/STROKEAHA.107.483131","article-title":"The interventional management of stroke (IMS) II study","volume":"38","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB381|cit381","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.STR.0000121641.77121.98","article-title":"Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study","volume":"35","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB382|cit382","series-title":"American Heart Association","first-page":"CT P44","article-title":"The Interventional Management of Stroke (IMS) III trial: an ongoing phase III trial","author":"Broderick","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB383|cit383","first-page":"597","article-title":"Barriers to the emergency use of thrombolysis for acute ischemic stroke: the INcreasing Stroke Treatment through INteractive Behavioural Change Tactics (INSTINCT) Trial","volume":"39","author":"Meurer","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB384|cit384","unstructured":"Scott P Morgenstern L INcreasing Stroke Treatment through INterventional behavior Change Tatics (the INSTINCT Trial) http:\/\/sitemaker.umich.edu\/instinct\/home"},{"key":"10.1002\/14651858.CD000213.pub2-BIB386|cit385","unstructured":"Scott PA INSTINCT. INcreasing Stroke Treatment through INterventional Behavior Change Tactics www.strokecenter.org\/trials\/TrialDetail.aspx?tid=688"},{"key":"10.1002\/14651858.CD000213.pub2-BIB385|cit386","unstructured":"Scott PA Silbergleit R Morgenstern LB Haan MN Kalbfleisch JD Cabana MD INcreasing Stroke Treatment through INterventional Behaviour Change Tactics www.abstractsonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&Re..."},{"key":"10.1002\/14651858.CD000213.pub2-BIB387|cit387","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1747-4949.2009.00243.x","article-title":"Comment on ITAIS","volume":"4","author":"Donnan","year":"2009","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB392|cit388","unstructured":"Wang Y Personal communication"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB388|cit389","first-page":"602","article-title":"Comparison of intravenous and intra-arterial tPA within 3-6 hours guided by multi-MRI: randomised study of 36 patients","volume":"39","author":"Wang","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB389|cit390","unstructured":"Wang Y Jiang W Zhao X Du B Dong K Liao X Imaging-based thrombolysis trial in acute ischemic stroke http:\/\/www.abstractonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&recordID=17703"},{"key":"10.1002\/14651858.CD000213.pub2-BIB390|cit391","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1747-4949.2009.00245.x","article-title":"Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II)","volume":"4","author":"Wang","year":"2009","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB391|cit392","unstructured":"Wang Y Wang Y ITAIS. Imaging-based thrombolysis trial in acute ischemic stroke http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=680"},{"key":"10.1002\/14651858.CD000213.pub2-BIB393|cit393","first-page":"213","article-title":"Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase","volume":"23","author":"Jin","year":"2000","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1002\/14651858.CD000213.pub2-BIB394|cit394","first-page":"S256","article-title":"Evaluation of intraarterial urokinase therapy in acute stroke","volume":"187 Suppl 1","author":"Kandil","year":"2001","journal-title":"Journal of Neurological Science"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB395|cit395","first-page":"589","article-title":"Partial recanalization after intraarterial thrombolysis: angiographic consequences and clinical outcome","volume":"39","author":"Kim","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB396|cit396","first-page":"187","article-title":"Evaluation of intravenous urokinase, ozagrel sodium and low molecular dextran therapy in acute ischemic stroke - comparison of infusion methods of urokinase","volume":"6","author":"Konta","year":"1996","journal-title":"Cerebrovascular Diseases"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub2-BIB397|cit397","first-page":"736","article-title":"Clinical observation on effect of tongnao huolo acupuncture therapy in treating acute cerebral infarction at ultra-early or acute stage","volume":"23","author":"Li","year":"2003","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB398|cit398","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/01.STR.0000202582.29510.6b","article-title":"Therapy of basilar artery occlusion. A systematic analysis comparing intra-arterial and intravenous thrombolysis","volume":"37","author":"Lindsberg","year":"2006","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB399|cit399","first-page":"303","article-title":"Efficacy analysis of DUM infusion interventionally on 33 cases of cerebral thrombosis","volume":"11","author":"Liu","year":"1991","journal-title":"Chinese Journal of Practical Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB400|cit400","first-page":"313","article-title":"Randomised controlled trial of Crack Ahylysantifarctase in treating cerebral infarction","volume":"16","author":"Yufeng","year":"1994","journal-title":"Beijing Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB401|cit401","first-page":"504","article-title":"Clinical observation of treatment through intravenous thrombolysis with urokinase for patients with early acute cerebral infarction","volume":"21","author":"Liu","year":"2004","journal-title":"Practical Journal of Medicine and Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB402|cit402","first-page":"42","article-title":"Study of correlation between times of a disease and plasma fibrinogen molecular reactivity in patients with acute cerebral infarction","volume":"7","author":"Lu","year":"2001","journal-title":"Hong Kong Medical Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB404|cit403","unstructured":"Haley EC Pilot study of TNK-TPA in acute ischemic stroke http:\/\/commons.cit.nih.gov\/crisp3...dit_numfound=53&p_keywords=stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB403|cit404","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.STR.0000154872.73240.e9","article-title":"A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke","volume":"36","author":"Haley","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB405|cit405","first-page":"246","article-title":"Pilot study of tenecteplase (TNK) in acute ischemic stroke: preliminary report","volume":"34","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB406|cit406","unstructured":"Lyden P Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke www.strokecenter.org"},{"key":"10.1002\/14651858.CD000213.pub2-BIB407|cit407","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.13.11.927","article-title":"Therapeutic thrombolysis in cerebral thromboembolism","volume":"13","author":"Meyer","year":"1963","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB408|cit408","first-page":"373","article-title":"Anticoagulants plus streptokinase therapy in progressing stroke","volume":"189","author":"Meyer","year":"1963","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB409|cit409","first-page":"419","article-title":"Microbubbles administration accelerates clot lysis during continuous 2 MHz ultrasound monitoring in stroke patients treated with intravenous tPA","volume":"36","author":"Molina","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB410|cit410","first-page":"30","article-title":"Microbubbles-enhanced sonothrombolysis for acute ischemic stroke","volume":"19 Suppl 2","author":"Molina","year":"2005","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB411|cit411","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.STR.0000199064.94588.39","article-title":"Microbubbles administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator","volume":"37","author":"Molina","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB412|cit412","series-title":"Stroke","first-page":"621","article-title":"Efficacy of microbubble-enhanced sonothrombolysis among stroke subtypes","author":"Rubiera","year":"2006"},{"key":"10.1002\/14651858.CD000213.pub2-BIB413|cit413","first-page":"39","article-title":"Effects of microbubbles-enhanced sonothrombolysis among stroke subtypes","volume":"21 Suppl 4","author":"Rubiera","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB414|cit414","unstructured":"Morris DC Abciximab and rt-PA in acute ischemic stroke treatment www.strokecenter.org\/trials\/TrialDetail.aspx?tid=481"},{"key":"10.1002\/14651858.CD000213.pub2-BIB415|cit415","first-page":"122","article-title":"Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis","volume":"113","author":"Naito","year":"1986","journal-title":"Folia Haematol (Leipz)"},{"key":"10.1002\/14651858.CD000213.pub2-BIB416|cit416","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7887\/jcns.6.84","article-title":"Acute thrombolytic therapy for middle cerebral artery occlusion","volume":"6","author":"Ohta","year":"1997","journal-title":"Japanese Journal of Neurosurgery"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB417|cit417","first-page":"229","article-title":"Clinical study of therapeutic effectiveness in treating ischaemic cerebrovascular disease with lumbrokinase","volume":"26","author":"Pang","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub2-BIB418|cit418","unstructured":"Dippel DWJ Dirks M Niessen L Huijsman R Minkman M Franke C PRACTISE. Promoting acute thrombolysis for ischemic stroke ISRCTN 20405426 unknown"},{"key":"10.1002\/14651858.CD000213.pub2-BIB419|cit419","unstructured":"Dirks M Niessen LW Koudstaal PJ van Wijngaarden J Minkman M Franke C PRACTISE: Promoting acute thrombolysis for ischemic stroke. A cluster-randomised trial of high intensity versus regular intensity implementation of thrombolysis www.esc-brussels.org\/esc_ongoing_trials.asp"},{"key":"10.1002\/14651858.CD000213.pub2-BIB420|cit420","unstructured":"Nederlands Trial Register PRACTISE: Promoting acute thrombolysis for ischemic stroke www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=311"},{"key":"10.1002\/14651858.CD000213.pub2-BIB421|cit421","unstructured":"On behalf of the PRACTISE Investigators Dirks M Niessen L Koudstaal PJ Franke C van Oostenbrugge RJ Huijsman R Indications and contra-indications for intravenous thrombolysis in acute ischemic stroke Unpublished"},{"key":"10.1002\/14651858.CD000213.pub2-BIB422|cit422","unstructured":"PRACTISE PRACTISE. Promoting acute thrombolysis for ischemic stroke www.practise-trial.org"},{"key":"10.1002\/14651858.CD000213.pub2-BIB423|cit423","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/qjmed\/hcl020","article-title":"Towards effective and efficient care pathways: thrombolysis in acute ischaemic stroke","volume":"99","author":"Wijngaarden","year":"2006","journal-title":"Quarterly Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB424|cit424","first-page":"16","article-title":"The dynamic study of stroke MRI in hyperacute stroke patients with thrombolysis","volume":"7","author":"Qiang","year":"2001","journal-title":"Hong Kong Medical Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB425|cit425","unstructured":"Qureshi AI Safety and efficacy of intra-arterial reteplase and intravenous Abciximab in patients with acute ischemic stroke www.strokecenter.org\/trials\/TrialDetails.aspx?tid=201"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB426|cit426","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1227\/01.NEU.0000232862.06246.3D","article-title":"Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, Phase 1 study","volume":"59","author":"Qureshi","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD000213.pub2-BIB427|cit427","unstructured":"Clinical Trials.gov ReoPro and retavase to restore brain blood flow after stroke http:\/\/clinicaltrials.gov\/ct\/gui\/show\/NCT00039832"},{"key":"10.1002\/14651858.CD000213.pub2-BIB428|cit428","unstructured":"Clinical Trials.gov ReoPro and retavase to treat acute stroke http:\/\/www.clinicaltrials.gov\/ct\/gui\/show\/NCT00046293"},{"key":"10.1002\/14651858.CD000213.pub2-BIB430|cit429","first-page":"A462","article-title":"Safety of combined abciximab and reteplase in acute ischemic stroke: interim results of ReoPro Retavase Reperfusion of Stroke Safety Study Imaging Evaluation (ROSIE)","volume":"62 Suppl 5","author":"Dunn","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB429|cit430","unstructured":"Dunn B Davis LA Todd JW Chalela JA Warach S for the ROSIE Investigators ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE) http:\/\/www.abstractsonline.com\/arch\/RecordView.aspx?LookupKey=12345&recordID=10974"},{"key":"10.1002\/14651858.CD000213.pub2-BIB431|cit431","unstructured":"Dunn B Warach S ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation http:\/\/www.abstractsonline.com\/arch\/RecordView.aspx?LookupKey=12345&recordID=16962"},{"key":"10.1002\/14651858.CD000213.pub2-BIB432|cit432","series-title":"Biometrics","article-title":"Patient-specific dose finding based on bivariate outcomes and covariates","author":"Thall","year":"2008"},{"key":"10.1002\/14651858.CD000213.pub2-BIB435|cit433","unstructured":"Warach S Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB436|cit434","unstructured":"Warach S ROSIE. ReoPro Retavase Reperfusion of Stroke Safety Study -- Imaging Evaluation http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=462"},{"key":"10.1002\/14651858.CD000213.pub2-BIB433|cit435","unstructured":"Warach S Butman J Davis L Dunn B Hsia A Latour L ReoPro Retavase Reperfusion in Stroke Safety Study -- Imaging Evaluation (ROSIE): interim safety and efficacy results http:\/\/www.abstractsonline.com\/arch\/RecordView.aspx?LookupKey=12345&recordID=16995"},{"key":"10.1002\/14651858.CD000213.pub2-BIB434|cit436","series-title":"The American Stroke Association 28th International Stroke Conference; 2003 Feb 13-15; Phoenix","first-page":"CTP40","article-title":"ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE)","author":"Warach","year":"2003"},{"key":"10.1002\/14651858.CD000213.pub2-BIB437|cit437","unstructured":"Davis L ROSIE-2. Reperfusion of stroke Safety study Imaging Evaluation - 2 http:\/\/www.strokecenter.org"},{"key":"10.1002\/14651858.CD000213.pub2-BIB438|cit438","unstructured":"Warach S Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB439|cit439","unstructured":"Warach S ROSIE-CT. ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation with Computed Tomography http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=438&printView=true"},{"key":"10.1002\/14651858.CD000213.pub2-BIB440|cit440","first-page":"260","article-title":"Thrombolysis in patients without MRI mismatch","volume":"34","author":"Rother","year":"2003","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB441|cit441","first-page":"101","article-title":"Clinical study on ultra-early intravenous thrombolysis with high-dose urokinase in treatment of acute cerebral infarction","volume":"80","author":"Shi","year":"2000","journal-title":"National Medical Journal of China"},{"key":"10.1002\/14651858.CD000213.pub2-BIB442|cit442","series-title":"Stroke","first-page":"e217","article-title":"Thrombotripsy study - safety and efficacy of acceleration of thrombolysis by TCCS","author":"Skoloudik","year":"2004"},{"key":"10.1002\/14651858.CD000213.pub2-BIB443|cit443","first-page":"180","article-title":"Efficacy of sonothrombotripsy versus sonothrombolysis in recanalization of intracranial arteries","volume":"13 Suppl 2","author":"Skoloudik","year":"2006","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB444|cit444","first-page":"21","article-title":"T-PA treatment increases circulating endothelial progenitor cells (SPCS) in acute ischemic stroke","volume":"23 Suppl 2","author":"Sobrino","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB445|cit445","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/STROKEAHA.106.465567","article-title":"Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke","volume":"38","author":"Ciccone","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB446|cit446","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.STR.0000154872.73240.e9","article-title":"A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke","volume":"36","author":"Haley","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB447|cit447","series-title":"American Heart Association","first-page":"CT P42","article-title":"TNK for ischemic lacunar syndrome - the TNKilas trial","author":"Wang","year":"2008"},{"key":"10.1002\/14651858.CD000213.pub2-BIB448|cit448","unstructured":"Haley EC Study of tenecteplase (TNK) in acute ischemic stroke (TNK-S2B) http:\/\/clinicaltrials.gov\/ct\/show\/NCT00252239"},{"key":"10.1002\/14651858.CD000213.pub2-BIB449|cit449","first-page":"14","article-title":"TNK induces faster MCA recanalization and better short-term outcome than native TPA. The TNK-TPA reperfusion stroke study","volume":"25 Suppl 2","author":"Molina","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB450|cit450","first-page":"563","article-title":"TNK induces faster MCS recanalization and leads to better short- and long-term clinical outcome than native tPA. The TNK-TPA reperfusion stroke study","volume":"39","author":"Molina","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB451|cit451","first-page":"71","article-title":"A biological syndrome predictive of cerebral bleeding in rtPA thrombolysis (data from the Lyon thrombolysis registry)","volume":"10 Suppl 2","author":"Troullias","year":"2000","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB452|cit452","unstructured":"Del Zoppo G Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB453|cit453","first-page":"133","article-title":"Vastt - the v10153 acute stroke thrombolysis trial","volume":"3 Suppl 1","author":"Hill","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB454|cit454","first-page":"abstract 26","article-title":"VASTT - the V10153 Acute Stroke Thrombolysis Trial","volume":"24","author":"Hill","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB455|cit455","unstructured":"Hill MD VASTT. The V10153 acute stroke thrombolysis trial http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=735"},{"key":"10.1002\/14651858.CD000213.pub2-BIB456|cit456","first-page":"45","article-title":"VASTT - The V10153 Acute Stroke Thrombolysis Trial","volume":"1 Suppl 2","author":"Pawsey","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB457|cit457","unstructured":"Vernalis Development Safety and efficacy study in acute ischaemic stroke www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD000213.pub2-BIB458|cit458","unstructured":"Vernalis Thrombotic disease: V10153 www.vernalis.com\/ver\/rdc2\/neurology\/v10153"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB459|cit459","first-page":"65","article-title":"A randomized, double-blind, placebo-controlled clinical trial of lumbrokinase capsules on the patients of blood rheology disorders with ischemic cerebrovascular diseases","volume":"13","author":"Wang","year":"1997","journal-title":"Chinese Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub2-BIB460|cit460","first-page":"485","article-title":"Observations of effect of defibrase in treatment of 30 cases with acute cerebral thrombosis","volume":"19","author":"Wang","year":"1999","journal-title":"Chinese Journal of Critical Care Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB461|cit461","series-title":"Proceedings of the 4th Chinese Stroke Conference; 1995 Oct; Chengdu","first-page":"44","article-title":"Thrombolytic therapy and external counterpulsation in acute cerebral infarction","author":"Xiang","year":"1995"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB462|cit462","first-page":"35","article-title":"Acute cerebral infarction treated by ahylsantinfarctase acupuncture: report of 60 cases","volume":"12","author":"Xu","year":"1997","journal-title":"Forum on Traditional Chinese Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB463|cit463","first-page":"124","article-title":"Comparison of the curative effects between ahylysantinfarctase and difibrinogenase on cerebral infarction","volume":"30","author":"Xu","year":"2000","journal-title":"Journal of Wenzhou Medical College"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB464|cit464","first-page":"359","article-title":"Clinical study on urokinase and nimodipine intravenous thrombolysis in acute cerebral infarction","volume":"20","author":"Xu","year":"2004","journal-title":"Chinese Pharmacological Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB465|cit465","first-page":"111","article-title":"High dose urokinase in the treatment of acute ischaemic stroke","volume":"3","author":"Yuan","year":"1995","journal-title":"Journal of Brain and Neurological Diseases"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub2-BIB466|cit466","first-page":"790","article-title":"Intravenous thrombolysis with urokinase in treating acute cerebral infarctions","volume":"24","author":"Zhang","year":"2003","journal-title":"Sichuan Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB467|cit467","first-page":"191","article-title":"Functions changes of VEC and therapeutic effect on VEC in patients with acute cerebral infarct","volume":"3","author":"Zhou","year":"1996","journal-title":"Zuzhong Yu Shenjing Jibing"},{"key":"10.1002\/14651858.CD000213.pub2-BIB468|cit468","unstructured":"Results of the FRALYSE randomized study: effect of the duration of rt-PA infusion on the functional outcome in patients with acute cerebral infarct Email dated 24 January 2009 from Eivind Berge"},{"issue":"10","key":"10.1002\/14651858.CD000213.pub2-BIB469|cit469","first-page":"924","article-title":"Effects of intravenous thrombolysis in treatment of acute cerebral infraction at early stage","volume":"15","author":"Lin","year":"2006","journal-title":"Chinese Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB472|cit470","unstructured":"Thijs V Personal correspondence"},{"key":"10.1002\/14651858.CD000213.pub2-BIB471|cit471","unstructured":"Thijs V MITI-IV. Intravenous administration of microplasmin for treatment of acute ischemic stroke http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=523"},{"key":"10.1002\/14651858.CD000213.pub2-BIB470|cit472","unstructured":"Thijs V Vosko Peeters A Aichner F Rother J Pakola S Double blind placebo controlled IV microplasmin administration in patients with acute ischemic stroke Powerpoint Presentation"},{"key":"10.1002\/14651858.CD000213.pub2-BIB473|cit473","unstructured":"Thijs VN MITI-IV Study Group Intravenous administration of microplasmin for treatment of acute ischemic stoke (MITI-IV) http:\/\/www.abstractsonline.com\/arch\/RecordPrintView.aspx?LookupKey=12345&RecordID=17591"},{"key":"10.1002\/14651858.CD000213.pub2-BIB474|cit474","first-page":"82","article-title":"Double-blind, placebo-controlled, intra-venous microplasmin administration in patients with acute ischemic stroke","volume":"3 Suppl 1","author":"Thijs","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB475|cit475","unstructured":"ThromboGenics Intravenous administration of microplasmin for treatment of acute ischemic stroke http:\/\/www.clinicaltrials.gov\/ct\/NCT00123305"},{"issue":"5","key":"10.1002\/14651858.CD000213.pub2-BIB476|cit476","first-page":"457","article-title":"Thrombolytic therapy using Actilyse (rt-PA) in patients with acute cerebral infarction","volume":"15","author":"Zeng","year":"2006","journal-title":"Chinese Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB477|cit477","unstructured":"EXTEND Ongoing study"},{"issue":"8","key":"10.1002\/14651858.CD000213.pub2-BIB478|cit478","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1553-2712.2006.tb01731.x","article-title":"A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology","volume":"13","author":"Guluma","year":"2006","journal-title":"Academic Emergency Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB479|cit479","unstructured":"Hemmem TM Cruz-Flores S Martin-Schild S Gomes JA Wijman CA Rapp KS Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L) http:\/\/asa.scientificposter.com\/epsView.cfm?pid=CTP43&vr=2008"},{"key":"10.1002\/14651858.CD000213.pub2-BIB480|cit480","series-title":"Proceedings of the International Stroke Conference; 2008 Feb 20-22; New Orleans (LA)","first-page":"CTP43","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L)","author":"Hemmen","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB481|cit481","first-page":"706","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L)","volume":"37","author":"Hemmen","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB482|cit482","unstructured":"Lyden PD Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB483|cit483","series-title":"Proceedings of the 2003 Annual Meeting of Taiwan Stroke Society; 2003 Mar 22-23; Taiwan","first-page":"104","article-title":"Thrombolysis for acute ischaemic stroke: the Third International Stroke Trial (IST-3)","author":"Chang","year":"2003"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB484|cit484","first-page":"480","article-title":"Thrombolysis for acute ischaemic stroke: the Third International Stroke Trial (IST-3)","volume":"9","author":"Hankey","year":"2002","journal-title":"Journal of Clinical Neuroscience"},{"issue":"7","key":"10.1002\/14651858.CD000213.pub2-BIB485|cit485","doi-asserted-by":"crossref","first-page":"416","DOI":"10.12968\/bjon.2003.12.7.11262","article-title":"Thrombolysis for acute ischaemic stroke: core nursing requirements","volume":"12","author":"Innes","year":"2003","journal-title":"British Journal of Nursing"},{"key":"10.1002\/14651858.CD000213.pub2-BIB486|cit486","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000091541","article-title":"Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial","volume":"21","author":"Kane","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB487|cit487","first-page":"76","article-title":"Consent for thrombolysis for acute ischaemic stroke","volume":"19 Suppl 2","author":"Kane","year":"2005","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB500|cit488","first-page":"e200","article-title":"The Third International Stroke Trial (IST-3)","volume":"35","author":"Kane","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB491|cit489","unstructured":"Kane I Sandercock P Lindley R Gubitz G Phillips S IST-3 Collaborative Group The MRC Third International Stroke Trial (IST-3) http:\/\/asa.apprisor.com\/snap\/NET\/GT\/700.cfm"},{"key":"10.1002\/14651858.CD000213.pub2-BIB492|cit490","unstructured":"Kane I Sandercock P Lindley R IST-3 Collaborative Group Third International Stroke Trial http:\/\/www.abstractsonline.com\/arch\/RecordPrintView.aspx?Lookupkey=12345&RecordID=10978"},{"key":"10.1002\/14651858.CD000213.pub2-BIB493|cit491","unstructured":"Kane I Sandercock P Lindley R IST-3 Collaborative Group Third International Stroke Trial http:\/\/www.abstractsonline.com\/arch\/RecordPrintView.aspx?Lookupkey=12345&RecordID=16913"},{"key":"10.1002\/14651858.CD000213.pub2-BIB498|cit492","first-page":"110","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase","volume":"17 Suppl 5","author":"Kane","year":"2004","journal-title":"Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD000213.pub2-BIB499|cit493","first-page":"e216","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase","volume":"35","author":"Kane","year":"2004","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB495|cit494","first-page":"450","article-title":"The Third International Stroke Trial: baseline characteristics of patients recruited in the expansion phase","volume":"36","author":"Kane","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB496|cit495","first-page":"295","article-title":"Third International Stroke Trial: characteristics of patients recruited in the start-up phase","volume":"35","author":"Kane","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB497|cit496","first-page":"i45","article-title":"The Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke: characteristics of patients randomised in the expansion phase","volume":"34 Suppl 1","author":"Kane","year":"2005","journal-title":"Age and Ageing"},{"key":"10.1002\/14651858.CD000213.pub2-BIB494|cit497","first-page":"29","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase","volume":"19 Suppl 2","author":"Kane","year":"2005","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB490|cit498","unstructured":"Kane I Sandercock P Lindley R on behalf of the IST-3 Collaborative Group The Third International Stroke Conference http:\/\/www.esc-brussels.org\/esc_ongoing_trials.asp"},{"issue":"9","key":"10.1002\/14651858.CD000213.pub2-BIB488|cit499","first-page":"1314","article-title":"The Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke","volume":"76","author":"Kane","year":"2005","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub2-BIB489|cit500","first-page":"797","article-title":"Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke","volume":"75","author":"Kane","year":"2004","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub2-BIB501|cit501","series-title":"British Association of Stroke Physicians Annual Scientific Meeting; 2005 Jan 19; Newcastle upon Tyne","first-page":"4","article-title":"Baseline CT characteristics of the first 253 patients in the Third International Stroke Trial","author":"Kane","year":"2005"},{"key":"10.1002\/14651858.CD000213.pub2-BIB502|cit502","first-page":"35","article-title":"Correlation of stroke subtype in OCSP classification and early ischaemic changes on CT: an analysis based on the first 389 patients from the IST-3 Trial","volume":"21 Suppl 4","author":"Kobayashi","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB503|cit503","first-page":"26","article-title":"Early ischaemic changes on CT and the OCSP classification: an analysis of the first 389 patients from the IST-3 Trial","volume":"13 Suppl 2","author":"Kobayashi","year":"2006","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB504|cit504","series-title":"Proceedings of the 16th European Stroke Conference; 2007 May 29 - June 1; Glasgow","article-title":"The MRC Third International Stroke trial (IST-3)","author":"Lewis","year":"2007"},{"key":"10.1002\/14651858.CD000213.pub2-BIB505|cit505","first-page":"A84","article-title":"The Third International Stroke Trial (IST-3): thrombolysis for acute ischaemic stroke","volume":"37 Suppl 2","author":"Lindley","year":"2007","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB506|cit506","first-page":"A7","article-title":"Persisting hyperdense artery sign, aspects scores and risk of developing mass effect: analysis from the first 389 patients in IST-3","volume":"37 Suppl 1","author":"Lindley","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB510|cit507","series-title":"Proceedings of the American Stroke Association 28th International Stroke Conference; 2003 Feb 13-15; Arizona","first-page":"CTP22","article-title":"The Third International Stroke Trial: thrombolysis for acute ischaemic stroke","author":"Lindley","year":"2003"},{"key":"10.1002\/14651858.CD000213.pub2-BIB509|cit508","first-page":"A96","article-title":"Thrombolysis for stroke - what are the 'grey' areas of uncertainty and are they changing? Results from the Third International Stroke Trial IST-3","volume":"38 Suppl 4","author":"Lindley","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB508|cit509","first-page":"A96","article-title":"Hyperintense artery sign, atrial fibrillation and infarct subtype in the Third International Stroke Trial (IST-3)","volume":"38 Suppl 4","author":"Lindley","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB507|cit510","first-page":"A62","article-title":"The Third International Stroke Trial. Baseline characteristics of patients recruited","volume":"35 Suppl","year":"2005","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD000213.pub2-BIB511|cit511","series-title":"Proceedings of the Conferenza Nazionale Sull'ictus Cerebrale; 2004 Mar 7-9; Firenze","first-page":"158","author":"Ricci","year":"2004"},{"key":"10.1002\/14651858.CD000213.pub2-BIB512|cit512","series-title":"Proceedings of the Conferenza Nazionale Sull'ictus Cerebrale; 2003 Mar 2-4; Firenze","first-page":"135","author":"Ricci","year":"2003"},{"key":"10.1002\/14651858.CD000213.pub2-BIB513|cit513","unstructured":"Ricci S Celani MG Righetti E Mazzoli T Thrombolysis for ischaemic stroke http:\/\/www.strokeforum.org\/Stroke2007\/Abstracts\/Freefiles\/ACTER_02.htm"},{"key":"10.1002\/14651858.CD000213.pub2-BIB515|cit514","first-page":"s439","article-title":"Baseline CT characteristics of the first 317 patients in the MRC Third International Stroke Trial (IST-3)","volume":"238 Suppl 1","author":"Sandercock","year":"2005","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD000213.pub2-BIB520|cit515","unstructured":"Sandercock P Lindley R The Third International Stroke Trial (IST3) http:\/\/www.eurostroke.org"},{"key":"10.1002\/14651858.CD000213.pub2-BIB519|cit516","series-title":"Proceedings of the British Association of Stroke Physicians Annual Conference; 2003 Jan 22; Stoke on Trent","first-page":"59","article-title":"Third International Stroke Trial (IST-3)","author":"Sandercock","year":"2003"},{"key":"10.1002\/14651858.CD000213.pub2-BIB517|cit517","unstructured":"Sandercock P Lindley R Wardlaw J Protocol 06PRT\/1269: Third International Stroke Trial (IST-3) http:\/\/www.thelancet.com\/journals\/lancet\/misc\/protocol\/06PRT-1269"},{"key":"10.1002\/14651858.CD000213.pub2-BIB518|cit518","series-title":"Book of Abstracts of the UK Stroke Forum Conference; 2006 Dec 7-8; Harrogate","first-page":"59","article-title":"The Third International Stroke Trial","author":"Sandercock","year":"2006"},{"key":"10.1002\/14651858.CD000213.pub2-BIB516|cit519","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1745-6215-9-37","article-title":"The third international stroke trial (IST) of thrombolysis for acute ischaemic stroke","volume":"9","author":"Sandercock","year":"2008","journal-title":"Trials"},{"key":"10.1002\/14651858.CD000213.pub2-BIB521|cit520","series-title":"Program and Abstract Book from the 12th Nordic Meeting on Cerebrovascular Diseases; 2003 Sep 17-20; Oslo","first-page":"26","article-title":"Third International Stroke Trial (IST 3)","author":"Sandercock","year":"2003"},{"key":"10.1002\/14651858.CD000213.pub2-BIB522|cit521","series-title":"Proceedings of the 17th European Stroke Conference; 2008 May 13-16; Nice","first-page":"Abst 4","article-title":"The Third International Stroke Trial (IST-3)","author":"Sandercock","year":"2008"},{"key":"10.1002\/14651858.CD000213.pub2-BIB523|cit522","first-page":"192","article-title":"Thrombolysis for stroke - what are the \"grey areas\" of uncertainty and are they changing? Results from the third international stroke trial (IST-3)","volume":"25 Suppl 2","author":"Sandercock","year":"2008","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB526|cit523","doi-asserted-by":"crossref","unstructured":"Sandercock PAG Lindley RI IST3 Stroke (http:\/\/stroke.ahajournals.org\/cgi\/content\/full\/34\/2\/e1) 2003","DOI":"10.1161\/01.STR.0000047037.38062.24"},{"key":"10.1002\/14651858.CD000213.pub2-BIB524|cit524","series-title":"Proceedings of the UK Stroke Forum Conference; 2007 Dec 4-6; Harrogate","first-page":"69","article-title":"The MRC Third International Stroke Trial (IST-3)","author":"Sandercock","year":"2007"},{"key":"10.1002\/14651858.CD000213.pub2-BIB525|cit525","series-title":"Proceedings of the UK Stroke Forum Conference; 2007 Dec 4-6; Harrogate","first-page":"71","article-title":"Thrombolysis for stroke - what are the \"grey areas\" of uncertainty and are they changing? Results from the Third International Stroke Trial (IST-3)","author":"Sandercock","year":"2007"},{"key":"10.1002\/14651858.CD000213.pub2-BIB514|cit526","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/jnnp.2007.126045","article-title":"Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3)","volume":"79","year":"2008","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub2-BIB527|cit527","first-page":"33","article-title":"Persisting hyperdense artery sign, ASPECTS score and risk of developing mass effect: an analysis based on the first 389 patients from the IST-3 Trial","volume":"21 Suppl 4","author":"Skowronska","year":"2006","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB528|cit528","first-page":"136","article-title":"Baseline CT characteristics of the first 137 patients in the start-up phase of the MRC Third International Stroke Trial (IST-3)","volume":"77","author":"Venables","year":"2006","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD000213.pub2-BIB529|cit529","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1747-4949.2007.00092.x","article-title":"The NeuroGrid stroke exemplar clinical trial protocol","volume":"2","author":"Wardlaw","year":"2007","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB530|cit530","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1747-4949.2006.00043.x","article-title":"Third International Stroke Trial","volume":"1","author":"Whiteley","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB531|cit531","series-title":"Book of Abstracts from the UK Stroke Forum Conference; 2006 Dec 7-8; Harrogate","first-page":"57","article-title":"The performance of UK centres in the Third International Stroke Trial","author":"Whiteley","year":"2006"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB532|cit532","first-page":"488","article-title":"CT appearance at baseline in the MRC Third International Stroke Trial: relationship with time from stroke onset to scan and stroke severity","volume":"38","author":"Whiteley","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB533|cit533","unstructured":"Intra-arterial urokinase trial Ongoing study"},{"key":"10.1002\/14651858.CD000213.pub2-BIB534|cit534","unstructured":"PROACT III Ongoing study"},{"key":"10.1002\/14651858.CD000213.pub2-BIB537|cit535","unstructured":"Toni D Personal communication"},{"key":"10.1002\/14651858.CD000213.pub2-BIB535|cit536","unstructured":"Toni D A randomised trial of alteplase in acute stroke www.agenziafarmaco.it"},{"key":"10.1002\/14651858.CD000213.pub2-BIB536|cit537","unstructured":"Toni D A randomized controlled trial of alteplase (rt-PA) vs standard treatment in acute ischemic hemispheric stroke in patients aged more than 80 years, where thrombolysis is initiated within 3 hours after stroke onset www.agenziafarmaco.it"},{"key":"10.1002\/14651858.CD000213.pub2-BIB538|cit538","unstructured":"Unknown Ongoing study"},{"key":"10.1002\/14651858.CD000213.pub2-BIB539|cit539","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000213.pub2-BIB540|cit540","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(05)60007-4","article-title":"Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis","volume":"352","author":"Ciccone","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB541|cit541","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis","volume-title":"Systematic reviews in health care: metaanalysis in context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD000213.pub2-BIB542|cit542","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/hcg016","article-title":"Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review","volume":"96","author":"Dundar","year":"2003","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1002\/14651858.CD000213.pub2-BIB543|cit543","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"3\/4","key":"10.1002\/14651858.CD000213.pub2-BIB544|cit544","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/jscd.2002.130044","article-title":"The NINDS Stroke Study group responses","volume":"11","author":"Grotta","year":"2002","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213.pub2-BIB545|cit545","first-page":"125","article-title":"Initial findings of the rt-PA acute stroke treatment review panel","volume":"16 Suppl 4","author":"Ingall","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB546|cit546","first-page":"57","article-title":"Meta analysis of thrombolytic therapy of intravenous urokinase in acute cerebral infarction","volume":"9","author":"Jin","year":"2000","journal-title":"Chinese Journal of Pharmacoepidemiology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB547|cit547","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.STR.0000125712.02090.6e","article-title":"In acute ischaemic stroke, are asymptomatic intracranial haemorrhages clinically innocuous?","volume":"35","author":"Kent","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB548|cit548","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.STR.0000150515.15576.29","article-title":"Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke. A pooled analysis of randomized clinical trials","volume":"36","author":"Kent","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB549|cit549","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/01.STR.0000190010.73274.e0","article-title":"Gender differences in tPA-related arterial recanalization (response)","volume":"36","author":"Kent","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB550|cit550","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/01.STR.0000173397.31469.4b","article-title":"\"Clinical-CT Mismatch\" and the response to systemic thrombolytic therapy in acute ischemic stroke","volume":"36","author":"Kent","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB551|cit551","first-page":"455","article-title":"Glycemic index predicts poor prognosis and risk of thrombolytic-related symptomatic intracerebral hemorrhage but does not appear to modify the effectiveness of rtPA therapy","volume":"38","author":"Kent","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB552|cit552","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(93)91945-I","article-title":"Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction","volume":"342","author":"Ketley","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB553|cit553","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.STR.0000164484.06950.77","article-title":"Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke","volume":"36","author":"Mann","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB554|cit554","unstructured":"National Institute for Health and Clinical Excellence (NICE) Stroke. The diagnosis and acute management of stroke and transient ischaemic attacks National Institute of Clinical Excellence, www.dh.gov.uk\/stroke 2008 1 37"},{"key":"10.1002\/14651858.CD000213.pub2-BIB555|cit555","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1001\/jama.286.22.2830","article-title":"Lack of clinical significance of early ischaemic changes on computed tomography in acute stroke","volume":"286","author":"Patel","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213.pub2-BIB556|cit556","unstructured":"The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD000213.pub2-BIB557|cit557","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","article-title":"Better outcome with early stroke treatment: a pooled analysis of the ATLANTIS, ECASS and NINDS rt-PA stroke trials","volume":"363","author":"The","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB558|cit558","volume-title":"A systematic review of the effectiveness, cost-effectiveness and barriers to the implementation of thrombolytic and neuroprotective treatment in the NHS","author":"Sandercock","year":"2002"},{"key":"10.1002\/14651858.CD000213.pub2-BIB559|cit559","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.STR.0000237086.85164.92","article-title":"Sex-based differences in the effect of intra-arterial treatment of stroke: a plea to stop torturing the old data and do large trials!","volume":"37","author":"Sandercock","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB560|cit560","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bmj.313.7059.735","article-title":"The relation between treatment benefit and underlying risk in meta-analysis","volume":"313","author":"Sharp","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000213.pub2-BIB561|cit561","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213.pub2-BIB562|cit562","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0967-5868(99)90596-9","article-title":"Thrombolysis in acute stroke pooling project: a metaanalysis on individual patient data","volume":"6","author":"Cornu","year":"1999","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000213.pub2-BIB563|cit563","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.STR.0000016923.99605.75","article-title":"Brain haemorrhage after thrombolysis: good or bad?","volume":"33","author":"Kummer","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB564|cit564","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s004150050512","article-title":"The influence of baseline prognostic variables on outcome after thrombolysis","volume":"246","author":"Wardlaw","year":"1999","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD000213.pub2-BIB565|cit565","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.STR.31.5.1133","article-title":"Trials of thrombolysis in acute ischaemic stroke - does the choice of primary outcome measure really matter?","volume":"31","author":"Wardlaw","year":"2000","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB566|cit566","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ewjm.176.3.198","article-title":"Thrombolysis for acute ischaemic stroke: still a treatment for the few by the few","volume":"176","author":"Wardlaw","year":"2002","journal-title":"Western Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB567|cit567","article-title":"Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke","author":"Wardlaw","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000213.pub2-BIB568|cit568","doi-asserted-by":"crossref","DOI":"10.1002\/9780470696361","volume-title":"Stroke: Practical Management","author":"Warlow","year":"2008"},{"key":"10.1002\/14651858.CD000213.pub2-BIB569|cit569","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.STR.23.12.1826","article-title":"Thrombolysis in acute ischemic stroke: does it work?","volume":"23","author":"Wardlaw","year":"1992","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213.pub2-BIB570|cit570","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000213.pub3","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"1995","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000213.pub2-BIB571|cit571","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/ACPJC-1997-126-2-035","article-title":"Meta-analysis: thrombolytic therapy increases the risk for early death and intracranial hemorrhage after acute ischemic stroke","volume":"126","author":"Wardlaw","year":"1997","journal-title":"ACP Journal Club"},{"key":"10.1002\/14651858.CD000213.pub2-BIB572|cit572","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(97)03022-5","article-title":"Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke","volume":"350","author":"Wardlaw","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD000213.pub2-BIB573|cit573","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000213.pub2-BIB574|cit574","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.STR.0000072513.72262.7E","article-title":"Thrombolytic therapy with rt-PA for acute ischaemic stroke: where do we go from here? A cumulative meta-analysis","volume":"34","author":"Wardlaw","year":"2003","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213.pub2-BIB575|cit575","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000213.pub2-BIB576|cit576","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1161\/01.STR.0000147964.46510.25","article-title":"Thrombolysis for acute ischemic stroke","volume":"35","author":"Wardlaw","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213.pub2-BIB577|cit577","series-title":"International Journal of Stroke","first-page":"50","article-title":"Thrombolysis for acute ischaemic stroke. An update of the Cochrane thrombolysis metaanalysis","author":"Wardlaw","year":"2008"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000213.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T00:00:00Z","timestamp":1406592000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000213.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T03:50:13Z","timestamp":1685159413000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000213.pub2"}},"subtitle":[],"editor":[{"given":"Joanna M","family":"Wardlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":577,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000213.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000213.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}